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Although it has been seventeen years since Werner
Schultz, (108) in Germany, described

a clinical syndrome,

which he called agranulocytosis, and which he believed
was a disease entity, there remains considerable confusion
as to many phases of the condition.

Kany writers have

refused to consider it as a true disease entity, and in
reviewing the literature of the published case reports
the reason for this becomes quite obvious.

Kany authors

have included all cases that show a leultopenia and neutropenia regardless of the clinical picture. Such reports
lead one to the conclusion that they are dealing with a
group of diseases.
The literature is especially voluminous in regard
to the etiology and treatment of agranulocytosis.

Kany

ideas have been offered but few have been generally accepted.

It is for this reason that the major portion of

this paper will be given over to a review of the established observations concerning the etiology and treatment
with an attempt to present the statue of these phases at
the present time.

For the sake of completeness, brief

consideration will be given to the history, pathology,
symptoms and signs, and the blood picture of the disease.
Agranulooytosia may be defined aa a grave condition
of

k~own

and unknown etiology, characterised by a marked

reduction of the total number of white blood cells, and
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a great reduction in the percentage of granulocytes, accompanied by aplastic, normal or hyperplastic myeloid
tissue.

following the peripheral neutropenia there may

be any number of lesions and symptoms

which might follow

the removal from the body of such an important defense
mechanism.

Characteristically these lesions consist of

necrotic ulcerations in the oral cavity but may also occur on the skin or mucous membranes elsewhere in the
body.

The disease may be aoute, chronic or recurrent.

IODIOLATURI
Werner Schultz, (108) in 1933, proposed the name
agranulocytoais.

The literature contains considerable

criticism of this term and consequently many different
ones have been offered in its stead.

friedemann, writ-

ing in 1933, being impressed by the usual severe localization of the process in the throat, suggested the name
"agranuloqt1c angina•. ( 121)

Thia name has been used

in the literature nearly as often as the original term
given by Schult&.

The term agranulocytosis came into the

nomenclature, no doubt, on account of its brevity; many
authors, however, believe it incorrect.
(107) said:

1

Victor Schilling

the term •agranulocytosis' has come into

the nomenclature on account of its brevity.

It is in-

correct; the name of •agranulooytes• was originally chosen for •neutrophils without granulations' of leukemias.
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By

1

agranulocytosia 1 is meant an .increase in these atyp-

ical neutrophils which is not intended. 1

The name agran-

ulooytic angina has also been criticized because of its
intrinsic ambiguity, and because it implies that one ia
dealing With an infection of the mouth which causes a
neutropenia, instead of with a syndrome of indefinite
etiology.

Stillman, (118) and Baldridge and Needles, (a)

have pointed out that the throat symptoms are not always
present.

Because of these confusing terms, many others

have been suggested.

Schilling (107) has stated that

"Jlalignant neutropenia1 is a more descriptive and appropriate term.
term.

Dameshek and Ingall (19) also prefer that

Baldridge and Needles (2) have called it

pathic neutropenia 1 •
the designation

1

1

idio-

litz-Hugh and Xrumbhaar (36) prefer

pernia1oua 1eukopenia1 which 1 silggests

certain analagies between this disease and pernicious
anemia•.

Linthicum (75) suggested the name •pyocyan1o

stomatitis with agranulocytio leulcopenia 1 because of the
etiological importance he attaobed. to the Bacillus pyooyaneoua.

Pelnar, (88) in 1925, called the condition

•malignant leultopenia•- Because he belieYed that it was
only one type of sepsis, reer (33) preferred the term
•sepsis agranulocytioa•.

In order to give due credit to

the man who a.roused interest in the condition, Rueper, l49)
has chosen the ne.me,
/fill"

1

.lgranulooytosis (Schultz)•.
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Roberts and Kracke (100) prefer

11

granulopen1a".

Rosenthal, (104) in his olasaifioatlon made according
to the clinical manifestations and course, divided neutropenia into malignant (fatal) and benign (recovered)
cases.

In reference to this classification, Beck (3)

stated that it might be well further to divide these into:
two main classes as follows: l. primary benign and primary malignant neutropenia, the true cases of benign and
malignant neutropenia, in which the etiology is unknown;

a.

secondary benign and secondary malignant neutropenia,

the oases 1n which the etiologic agents are evident or
in which one is dealing with examples of well recognized
clinical entities.
HISTORY
If agranulocytosis had existed to any great extent
prior to 1922, it undoubtedly would have been described
long before, since the disease runs such a dramatic course
and often

te~minates

fatally.

Blood counts have been made

as a routine procedure in most large hospitals for the
past fifty years.

Werner Schultz, (108) in 1923, first

fully described four oases in middle aged women characterized by gangrenous throat lesions, severe leultopenia, a
decrease or absence of granular cells in the peripheral
blood, and a rapid septic course with death in from two
to seven days.

He.

noted the frequent association of jaun-

dice, the persistence of a normal red blood cell count
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and the scarcity of myeloid cells found in the bone
marrow at postmortem examination.

Schultz is thus given

credit for recognizing the syndrome later named agranulocytic angina by Friedemann, but, Pepper (90) states:
•no one believes that the condition had not previously
been seen•.

AD editorial in the Journal of the .American

Kedioal Association (31) quotes Turk as describing similar oases in 1907, although he did not distinguish them
from the commoner leukopenia of overwhelming infection.
Pepper, (90) in his history of agranulooytic angina, ataied
that standard laryngologic works of fifty years ago apparently described this disease under the heading •putrid sore
throat• and •gangrenous angina", and he said that Kaotenzie,
in his manual of diseases of the throat and nose, credited Gubler, in 1857, and Trousseau, in 1865, with having
clearly distinguished the disease from diphtheria.
In 1902, Brown. (13) reported •a fatal case of acute
primary 1.nfeotioua phal"Jngitis with extreme leukopenia•.
The case was that of a 28 year old married woman who died
seven days after the onset of a sore throat.

At the on-

set she experienced chilliness and a sudden rise of temPerature to 103.
enlarged.

The spleen and lymphnodes were slightly

The blood picture showed: leukocytes 1000 with

one per cent polymorphonucleare, 83 per cent small lymphocytes and 16 per cent large lymphocytes.

On the third
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day·of the illness the leukocytes were 400 and on the
fourth day they were 320.
was 105.4.

The temperature at that time

There was a gradual increase in swelling of

the tonsils and pharynx.

Cultures of the throat showed

Staphylococcus aureus and al.bus.

The urine showed al-

bumin, casts and red blood cells.

On the seventh day

day •so few leukocytes were found that neither a fair
estimate of the total number could be made nor were
enough found on six coverslips to make a differential
count•.

The Patient died on the seventh day from edema

of the glottis.
. Leale, ( 72) in 1910, reported a case in a male child
two and one-half months old under the title,

1

Recurrent

furunoulosis in an Infant Showing an Unusual Blood Picture •.

He described the case of a baby who was subject

to repeated attacks of furunculosie, with accompanying
fever and prostration all out of proportion to the clinical
findings, and who also presented the unusual blood picture
of leukopenia and lymphooytosis without other marked blood
changes.

He was at a loss to explain the unusual blood

changes and carefully ruled out lymphatic leukemia, malaria,
rickets, scurvy, and infectious disease.
1

He concluded:

In all probability, the fever is to be accounted for by

the toxemia generated by the staphylococcus pyogenes aureus during the attacks of furunculosis, but this does not
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satisfactorily account for the peculiar blood findings.•
Baldridge and Needles (2) reported a case that occurred
in 1910, pointing out that in former years it either was
overlooked because the bloOd was not examined, or was
interpreted as a &Jlllptom of exhaustion of the bone marrow,
aleultemio leukemia or aplastic anemia.
In 1923, Schultz (108) reported the four cases as
described previously, and applied the

term

agranulocytoais,

and he stated the belief that it was a distinct clinical
entity.

from that date interest in this symptom complex

has continually increased.

In 1924, Lovett (76) reported

the first case in this country following Schultz• description of the syndrome.

Sbe reported that about a dozen

oases of the disease bad been reported in Germany, and
that her case was a similar one.

She stated that the main

features were ulcerative angina, usually accompanied by
icterus, a great reduction in the white blood cells,
af f eoting chiefly the polymorpbonuolear leukocytes and a
~atal

outcome after an acute course.

Sbe added that there

was no anemia and that the granular cells were absent not
only from the blood, but also from the bone marrow.

Since

her report in 1924, many cases have been reported in this
country and abroad and many theories as to the pathogenesis and treatment suggested.
Further interest was aroused in this country following
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the report of R. R. Kracke, (65) in 1931, in which he
first drew attention to the fact that his patient had
used large amounts of benzene ring drugs for three years
preceding her illness, and stated that the association
between her illness and the drugs should be considered

of etiological importance.

Plumer's (93) report of a

fatal case of agranulooytoaia in April, 1937, which occurred following the administration of sulfanilamide,
marked the opening of the latest chapter in the history

of this interesting condition.
PATHOGENESIS
In reviewing the literature one finds many explanations and hypotheses of the pathogenesis of agranulocytosia.

An attempt has been made to group these hypo-

theses so that they may be presented more clearly.
Predisposing Causes.-- It is exceedingly difficult
to extimate the true incidence of the disease, first
because an unknown number of oases are not recognized
owing to the lack of an examination of the blood and,
second, because all oases in which there is a marked
leukopenia cannot be classified as instances of true
agranulocytosis.

ror example, Doan (27) stated that only

twenty percent of patients with leukopenia referred to
his clinic have true agranulooytosis.

It should be em-

phasized that extreme leukopenia may occur secondary to
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sepsis in cases of various diseases of the blood, such
as aplastic anemia, aleultem1o leukelll1a and pernicious
anemia. (121)

l'itz-Bugh and Oomroe (35) regard leukopenia

which occurs in association with those blood disease• or
following the therapeutic use of arsenic or gold preparations, or after exposure to benzene as a •mere heaatological manifestation• of some other disease and not
agranulocytos1s.
Schultz described the condition as occuring in middle
aged women.

Hueper .(49) reviewed 125 oases he found in

the literature in the six years following Schultz's original article and oonclud.ed that 77.5 per cent of the caaes
had occurred in women.

Xastl1n, (62) in 1927, in a sta-

tistical review of the reported oases at that time found
43 oases reported with 34 of the oases appearing in females,
or 78 per cent.

Jackson (53) found that 82 per cent of

the reported oases up to 1937 had been women.

•rour women

to one man• is the sex incidence as given by Kracke. (68)
Roberts and Xracke (100) studied the problem of granulopenia in 8 1 000 ambulatory private patients, and found that
one of every four patients in a general practive may be
expected to have a mild granulopenia.

However, they found

that only 56 per c·ent of the mild granulopenias occurred
in

female patients.

Beck (3) concluded that in the final

analysis, it may be foun4 that neutropenia, chronic and
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acute, does not predominate in either sex.
Jackson (53) found that 76 per cent of the oases
were in patients between the ages of 38 and 65 years.
l:astlin (62) found the average to be 46 years.

l:racke

(66) stated that it may occur in infants or the aged.

He

has observed a patient 72 years old with agranulocytosis.
Beck (3) stated that practically all of the typical oases
of primary benign and malignant neutropenia have occurred
in the fourth decade of life--from 41 to 58 years of age.
Jackson (53) observed that most of the cases have
occurred in obese women complaining of gall bladder symptoms.

Beck (3) also mentions the coincidence of previous

disease of the liver and the gall bladder with malignant
neutropenia.

In his review of the 1DC1dence of the dis-

ease, Xastlin (62) found a negative history of past illness in 62.8 per cent of the oases.

There seems to be no

definite relationship of agranulocytoais to season.

Bo..,.

'ever, Kracke (66) believes that it may be somewhat more
prevalent in the winter because of the
tion with influenza•.

1

frequent associa-

As to geographical limitation

Kracke stated that 80 per cent of the reports are found
in Germa.n and American literature.

He added that it·was

comparatively infrequent in France and England, rare in
Italy, and extremely rare in the Orient.

l:racke believes

that this distribution can be correlated to the usage of
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organic chemical oompounda 1 because

1

in Germany and the

United States is found the widest usage of organic chemical compounds and aniline dye products•.

Similarly,

Beck (3) lists as other predisposing causes those drugs
and chemicals containing the benzene ring, the arsenicala 1
trinitrotoluene,

X-rays etc.

She also believed that

•certain infections• might be predisposing causes; such
oases she groups under the headings of secondary benign
and secondary malignant neutropenia.
Kracke (66) finds th&t the condition seems peculiarly
prevalent in
1

1

ladies and gentlemen of leisure• or the

better class•..

He also states that the disease is prac-

tically confined to the white race.

lladison and Squier (78)

have found the condition especially prevalent in doctors,
nurses, drllggists,students, and other people associated
with the medical profession.
Organisms as a Cause.-- The first reports of.agranulocytosis show that the authors

considered the condition

as an infectious disease or at least the result of some
form of sepsis.

Schultz, with the idea that a nervous

factor was involved, stated.:

1

It may be assumed that the

affection involves an extensive injury of the spinal cord
in the domain of the granulocytic system, caused by infection•. (40)

Lovett,in 1924 1 (76) in the first report

of the disease made in this country, said:

1

Is it a local
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infection with a specific organism which produces severe
gangrenous lesions, and has a toxic effect on the granulocytes, or is it primarily an injury to these cells at the
site of their formation, with a consequent lack of general
resistance, so that any infeo'tion goes on to necrosis and
finally deathT 1

She obtained Bacillus pyocyaneous in

cultures from the oral lesions and from the spleen and
attached great significance to this discovery.

Experi-

mentally Lovett claimed that this organism had the power
of reducing the leukocytes in the blood of guinea-pigs, and
causing degeneration of leukocytes in the peritoneal cavity.
She concluded: "The disease appears to be due to an injury
to the leukopoietic element of the bone marrow, with lowered bodily resistance and necrosis in various parts.

The

etiology and pathogenesis are not explained, but from the
similarity of all cases so far reported, one must regard
it as a clinical entity.•
Koore and Wieder, (83) in 1925, reported a case of a
.
woman, aged 42, who recovered from a first attack but died
of an attack two years later.

J'rom their observations .of

this case, these authors stated as to the etiology of the
condition:"nothing definite has been found; it seems 'tha.t
an infectious toxin having an affinity for, and spending
its force on, the neutrophil producing structure of the
bone marrow is the important factor in causing the disease•.
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Zadek, (133) in 1925, concluded from the atypical cases
of agranulocytosis, that it was not an independent disease,
but only •an abnormal type of reaction•.

Piette, (91) in

1925, after histological examination of the liver, spleen,
kidney, stomach, auprarenal and ovary from Skiles'(l14)
Case, concluded:

'As

f~

as the unfortunately incomplete

microscopic examination permits me to form an opinion,
the following is suggested as the possible pathogenesis:
The lesions were due to bacterial emboli and were but
secondary lesions as a consequence of the septico-pyemia.
Bacilli enter the human organism by some unknown route,
rapidly destroying all the polymorphonuclear leukocytes;
then they multiply and give rise to numerous embolisms
throughout the body, meeting with no opposition or reaction.

Only the reticulo-endothelial system of the spleen

and to a lesser degree of the liver, which show progressive changes, make any attempt to combat the invader.

The

lymphocytes which are immune to the destructive virus are
unable to entirely defend the body.

Some elimination occurs

through the kidneys, where the bacilli are moat abundant
and where they are found in large numbers within the excretory ducts.•

Piette (91) was tlnable to obtain positive

blood cultures and thus

1

identify the causal organism".

He said: "if they belong to the Bacillus pyocyaneous
species they must possess some peculiarities in their
biologic properties.•
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Pelnar (88) described a case of acute leukemia, in
1934, with a low leukocyte count (dropping from 4,?50 to
1,070) and a low percentage of neutrophils.

Be felt that

the low neutrophil counts seemed to be especially malignant when combined with low absolute counts.

He did not

feel, however, that agranulocytos1s deserved separation
as a different entity but grouped all the septic or leu·kemic conditions with this syndrome under the name,
•malignant leukopenia•.

leer (33) noted leukocyte counts

below 3,000 in 186 of 29, 498 patients (0.63 per cent),
among them 13 patients with counts below 1,000.

All of

the 13 died shortly afterward, with the exception of one
woman with Banti's disease.

reer believed that agranulo-

oytosis was only one type of sepsis.
Blanton, (6) in 1923, observed a 60 year old man with
an unexplained

iemp~rature

of 101, a slightlJ red and sore

throat, and marked prostration.
localizing symptoms or signs.

There were no definite
The leukocyte count was

1,340 with an entire absence of pol711orphonuclears.

Ten

days later fiuctuation was noted at the aide of the neok
and pus laden with hemolytic staphylococci was evacuated.
Although multiple abscesses developed, the patient eventually recovered, and the blood picture changed to normal.
Blanton concluded:

~This

might be cited as an illustration

of an extreme leuoolysis due to specificity of a bacterial
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poison for white cells in the blood stream and bone
marrow.•

In 193?, Bart (45) reported two cases of

agranulooytosis oocurring in sisters, ages 32 and 42.
Blood cultures gave a pure growth of lriedlander•s bacillus.

The author believed that these cases were real

septicemias and that the low blood count was merely indicative of an overwhelming infection.

Linthicum, (75)

in 1927, wrote: •agranulocytosis may be associated with
a stomatitis caused by any of the pyogenic organisms•.
He believed, however, that there was a definite clinical
entity, somewhat similar, which was always fatal and.
caused by the Bacillus pyocyaneous; thus he gave it the
name •pyocyanio stomatitis with agranulocytic leukopenia•.
Sachs, (106) writing in the lebraska State Kedioal
Journal in 1928, said that agranulooytosis was •probably
not a disease entity but the failure of the bone marrow
to respond to a severe infection of unknown etiology•.
He believed that the condition was not especially rare
and that in all probability it was being mis-diagnosed as
streptoooooio sore throat. · Be was also of the opinion
that agranulooytosis was very sillilar to a llilder group
of oases called

1

infectioua mononucleosis' and that in all

probability both were due to the same etiological factor.
StillJJail, (118) in 1928, expressed the belief that agranulocytosia was probably related to monocytic angina and
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glandular fever, and that it might represent the severe
form of these conditions.

He thought that the condition

was a special form of reaction on the part of the hematopoietic system to infection, rather than the result of
the activity of a special infective agent.
1

He concluded:

Agranulocytosis is probably due to the activity of some

extermal stimulus operating in individuals exhibiting a
constitutional predisposition' and

1

ihis external stimu-

lus is most frequently some form of infection, and oondi tions are suoh that even the Bacillus pyooyaneous may
at times play a significant part in the etiology•.
In 1928, Heuper (49) made an extensive review of the
subject and concluded that the majority of workers up to
that time were of the opinion that the condition was an
infectious disease and represented a septicemia with an
atypical reaction of the hematopoietio system due either
to bacteria with a special affinity and toxicity to the
granulocytic system or to an atrophy or hypoplasia of this
organ because of the presence of a septic infection.
According to his study, the investigators in the field
believed that the bacterial causes were either specific or
non-specific.

Dayton, (23) in the same year concluded

that absence or reduction of granular cells might be caused
by a variety of toxic agents including bacterial invasion.
Rose and Houser, (102) stated in 1929;

1

The available
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evidence does not justify a conception of so-oalled
agranulocytos~a

disease entity.

or agranulocytic angina as a specific
On the contrary, the known faots con-

cerning the reported cases would indicate that the picture produced is the result of non-specific reaction to
an infection of unusual absolute or relative virulence,
and that a variety of infecting organisms may possibly

play a part in its production.•
Keyer and Rosenberg, (80) in 1930, would not believe
that the condition was a disease entity and were

1

inclined

to view it as a terminal reaction in a subject who had
had a previous debilitating disease or overwhelming infection•. Dameahek and Ingall, (19) in their review of

aoo

oases in 1931, found that most authors believed that

the blood picture was due to a marked effect on the myeloid cells by a septic or toxic process the nature of
which.was unknown.

They stated that Stocke concluded that

there are imperceptible transitions from pure or typical
agranulocytosis .to the

~~

course of sepsis with rather

an unusual type of leukopenia, and that agranulocytosis
was not a special disease, but an abnormal reaction to
sepsis.
With the prevalent belief that agranulooytosis was
'

caused by an infection or septic process, it is not surprising to find the reports of many men describing their .
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attempts to reproduce the disease by injecting into
animals organisms isolated from lesions, from the bone
marrow and from the blood stream of patients suffering
o~ de~

from the disease.

Lovett•s (76) work, in 1924,

of injecting Pyocyaneous bacilli into guinea-pigs and
causing a reduction of the leukocytes was the first work
of this type attempted.

In 1928, Dasse (31) reported a

oaee in which throat cultures gave an almost pure culture
of Bacillus pyocyaneoua.

He made injections of living

cultures of this organism subcutaneously into guinea-pigs
and produced a slight reduction in the white
and

1

blood oount

alwaya a relative reduction of the granulooytes from

68 to 30 per cent•.

Kracke, (66) in 1933, expressed

doubt in the results of Lovett 1 s experiments.

He felt

that the granulopenia she produced was not below that
which can often be observed in normal guinea-pigs.

He

isolated the Bacillus pyooyaneus from the blood stream
in a patient dying from agranulocytosis but was not able
to

1

disturb the blood picture• in rats and guinea-pigs

with the bacteria.

He said to his knowledge that •no

one has been able to•.

'However,• be added,

1

'1'his does

not mean that it should be ruled out as a possible causative factor.•

Kracke tried various organisms with no

success and believed others had all failed.

He stated

that bis results and those of others were •further
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evidenoe that some other type of toxic agent depresses
the bone marrow, resulting in a.u overwhelming infection
by any or every organism that happens to be residing in
the gastrointestinal tract•.

He did not attach etiolog-

ical importance to pathogenic spirillium,which had been
thought a factor in the disease due to the fact that a
large number of reported cases had a history of being
treated for Vincent's angina,but dismissed this point by
saying that the mouth infection occurs because of a lowered cellular resistance of chronic granulopenia, or because of an unrecognized attack of acute granulopenia.
Kracke has been unable to discover and spirillium in
autopsy or biopsy studies under dark field.
Fried and Dameshek, {38) in their experimental work
of producing neutropenia, infected rabbits with Salmonella
suipestifer by way of the blood stream.

By injecting

small doses or overwhelming doses they could produce two
types: l. Cases in which the animals recovered;:·a. t\11.llinating oases ending fatally. The blood picture showed leukopenia
and neutropenia.

In the oases in which recovery occurred

the bone marrow showed areas of necrosis with patches of
proliferation.

In the fulminating cases there was but

little evidence of myeloid proliferation.
concluded:

1

These workers

The results have shown that there are close

similarities between the agranulocytoaia resulting from
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Hematogenous infection ·of rabbi ts with Salmonella:
suipestifer and that observed in oases of agranulocytic
angina in man. 11
Dennis (24) approached the problem from a slightly
different angle in a group of experiments carried out
to teat the hypotheaia that leucocidin producing organisms (Staphylococcus aureus, Streptococcus hemolyticua,
Streptococcus viridana, and Paeudomonaa aeruginoaa) restrained from active invasion of the tissues, but so
situated that their diffusible toxic products could be
absorbed, were capable of producing granulopenia. The
experiments were performed by inserting a "diffusion
capsule", containing a serum broth culture of the organism to be studied, into the peritoneal cavity of a rabbit.

In this way, he hoped to prevent any local tissue

reactions to the organisms but hoped to cause an absorption of their toxic products.

He found that Staphylo-

coccus aureus, Streptococcus hemolytious and a species
of Proteus each produced a •more or leas chronic granulocytopenia• which terminated w1 th a fatal infecti·on by
a different bacterial species.

Streptococcus viridane

showed surprising virulence, producing an acute leukopenia within a few hours.

Dennis believed that the pic-

ture produced in rabbits by Streptococcus viridans toxin
was •analogous with that of acute agranulooytosis in man•.
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His concept of the usual origin of the clinical agranulooytio syndrome is that there is a •primary focus of infection by one of the leucooidin-producing organisms from
which leucocidin is diffused into the blood stream where
it affects the neutrophils, and if present in sufficient
quantities and toxicity it injures the granulopoietic
elements of the bond marrow.u

He thus suggested that

agranulocytosis in man is due to the action of leucooidin, rather than to a specific microorganism.

This work

was not confirmed by Meyer and Thewlis (81), however, who
attempted also to show that encapsulated pyogenic bacteria,
acting as a focus, produce granulopenia.

They used the

same procedure that Dennis used and did produce an acute
leukopenia and death of a rabbit in 40 hours but they
found no •significant decrease in the per centage of
neutrophils in the blood 1 •
Harrie and Schattenberg (44) in 1935, studied the
effect on experiimental animals of the subcutaneous,
intraperitoneal and intracardiac injection of B. enteritidis, B. welchi, and Streptococcus hemolyticus and
the toxic products derived from these bacteria.

The

toxic material was prepared from the exudate obtained
from guinea-pigs with fatal peritonitis which was induced by these organisms and was then passed through a
Berkefeld or

Seitz-~z

filter.

When this filtrate
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was injected parenterally into guinea-pigs, •granulopenia was induced".

These workers concluded that there

was some doubt as to whether the condition they produced
was a true reproduction of the human disease, and also
that their experiments indicated to them that agranulocytosis was due to varied causes.

In 1936, Isaacs and

his co-workers (51) stated "Despite various attempts it
cannot be said that it is possible to produce tnue
agranulocytosis in animals.

This is not surprising if it

is agreed that the condition occurs only in certain
persons Who are susceptible.
The idea that agranulocytosis was caused by a septic
agent

=a:a

met with considerable Ol:iticisms from many of

the men interested in the subject who felt that the
septic aspects of the condition were only secondary and
not of importance etiolcgically.

Vos and Staal (126) in

reporting a case concluded that agranulocytosis was due
to a lesion involving, exclusively, the leukopoietic
function of the bone marrow and that the "gangrene and
sepsis are secondary and the role of the tonsils is
without importance in the etiology•.

Werner Schultz

(109) in 1927, in reporting a case of "atypical tonsilitis • which he believed was actually agranulocytosis,
stated that the toneilitis appeared late which "speaks
for the theory that the tonsil is only a point of
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localization of the disease, not the portal of entrance".
Hueper stated, in 1928, (49) that the demonstration of
bacteria in the blood of patients with agranulocytos1s
•1s not proof of the infectious character of the disease
because bacteria are also frequently found in later
stages of leukemias and their presence is due to invasion
of the body through the

a~eaa

of necrosis•.

.Also in

1928, Dayton (23) stated "The necrotic condition of the
mouth and throat and other mucous membranes is secondary
~o

the agranulocytosis and due to the absence of the

defensive posers of the leukocytes, since it is commonly
found when this condition is present, regardless of the
nature of the causative agent.•

Rosenthal (103) conclud-

ed in his observations, in 1930, that the septic manifestations •are of a secondary nature and produce pathological lesions which are Q,ommon to s'ptic coildi tione without
the inflammatory reaction•.
It remained far Roberts and Kracke (99) in 1930 to
offer definite clinical proof that the septic manifestations were of secoIXiary importance in the disease.
·They reported in that yea:r a case of a 72 year old woman
who survived a first attack of agranulocytosie.

Following

her recovery she was confined to the hospital for observation.

Daily blood counts were made although she was

clinically well.

Two months following her first attack

it was noticed that there was a sudden drop in the leu-
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kooyt·e count and that the polymorphonuclears entirely
disappeared.

The patient was clinically well even then,

but on the fourth day following the first change
blood picture she

became-~

the

~b

acutely ill with typical

symptoms and signs of agranulocytosis and died three days
later.

From their observation of this case Roberts and

Kracke offered the

followi~

as an explanation of the

mechanism involved in the production of the disease:
"The bond marrow before the clinical onset had ceased to
manufacture granulo'cytes.

'l'he marrow evidently passes

through a period of dysfunction to complete &function
in a case presenting total absence of the polymorphom:lears.

But the primary lesipn, the primary dysfunct-

ion, the primary afunction is in the myelocytic division of the marrow even before the clinical onset.

The

disease exists in the bone marrow before it appears in
the blood stream and in the blood stream before it appears clinically.•

In 1931, Iraoke (65) made similar

observations in a case of a 44 year old woman lib. o had
recurrent acute.attacks of agranulocytosis interspersed
with prolonged periods of chronic granulopenia.

By re-

corded blood counts during the periods of chronic
granulopenia he again observed that the onset in the
bone marrow preceded the appearance of clinical symptoms.

,...,...,

.

In another paper

wr~ t_ten

in 1932, Kracke ( 66) stated.:
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1

I believe it can be reasonable assumed that agranulocy-

tosis is primarily a disease of the myeloblastic tissues, followed by loss of resistance resulting in overwhelming infection.•

In the same paper he appeared, how-

ever, to attach some etiological importance to infection.
He stated that it might be possible that the bone marrow
depression was caused by 'hidden or latent infection over
a long period. 1 , so that when the •resistance fell to a
low ebb 0 , acute infection followed because the myelocytio
tissues.were "unable to meet the emergency•
the number of cases he had seen following

He felt that

influenz~

after

a variable length of time added support to this view.

He

said, "Since the infecttng agent of influenza tends to
produce a leukopenia, it is quite possible that the residuals of the 1nf ection produce a slow and gradual damage
to the bone marrow from which it is unable to recover•.
In 1928, Heuper and O'Oonnor (50) wrote,

1

The infectious

origin and character of the disease as asserted by numerous authors seems to us not proven.

The presence of

streptococci or other bacteria in the blood is not considered by us as a primary condition, but as a secondary
one due to an invasion of these bacteria through the
necroses in the mouth•.

They believed that all cases

reported as agranulooytosis which developed this symptom
complex following "a purulent infection and showing

as

evidence of suppuration, generalized hemorrhagic diathesis,
secondary anemia, myelocytie reaQtion in the blood and
bond marrow• could not be recognized as •essential• agranulocytosis but were •probably more correctly classified
as septic infections with an agranulocytic symptom complex•
which are also observed in man other diseases, as aleukemio
leukemia, pernicious anemia, oarcinosis or the bone and
abdominal lymphogranulomatosis.
The oase reported by Rutledge and his co-workers (105)
of a patient showing periodic neutropenia tends to eliminate the hypothesis that agranulocytosis is due to a septic
process acting on the myeloid tissue.

Th~ir

case was one

in which cyclic, agranulooytio angina associated with fever
and constitutional symptoms, but without anemia, began at
the age of two and one-half years and recurred at intervals
of approximately three •eeks, during the entire life of a
man ao years of age.
medical literature.

Th._is case is apparently unique in
This is the· same case reported by

Leale (72) in 1910 as •Recurrent rurunculosis in an Infant
Showing an Unusual Blood Picture• and was described earlier
in this paper in the History.

Case number three in Doan•s

(65) series also showed a periodic recurrence.
Hyperergic Inflammation.--A few authors believe that
agranulocytosis may be a form of hyperergic inflammation
(allergy) in which the bone marrow is the point of least
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resistance.

Schilling (107) has produced a blood picture

similar to agranulocytosis experimentally in a.naphylaxis
so that he thinks it may be an anaphylactic condition
instead of an individual disease.

In as review of agranu-

locytosis in 1931, Pepper (89) stated:

•studying the cases

I have seen for some common factor, I have been struck by
the presence of allergy in each.

This may, of course, be

a mere coincidence, but this is unlikely for allergy occurs
in only ten per cent of the race.

I am sufficiently im-

pressed by the evidence to suggest that a.granulocytic
angina may have allergy as the background.•

In 1929,

Bromberg and Murphy observed a fatal case of agranulooytosie following prophylactic typhoid vaccination.

They

stated that the abnormal reaction of the hematopoietic
system occurred so directly after the injections that it
suggested that they •may have been the toxic agent that
incited the clinical manifestations' of agranulocytosis.
Kracke (65) reported a case 1n 1931 in which a woman failed
to recover from the final dose of typhoid vaccine innooulation.

She remained in bed with daily fever and extreme

weakness for thirty days, culminating in three attacks of
agranulocytosis.

Kracke said:

8 The

question of typhoid

prophylaxis as a whole or partial ca.use of the condition
must be eonsidered. 0

Beck (3) brought out the fact that

inactivated typhoid bacilli have a marked ohemotaotio effect

3·8

on the bone marrow.

She stated that a few of the cases had

shown eosinophilia in further support of the theory of
anaphylaxis, but she added that these cases may have resulted from an overwhe1ming reaction to foreign protein
in a sensitive subject.
Congenital and Familial Bone Karrow Inadequacy.-- A
familial tendency to diseases of the hematopoietio tissues
of one type or another presents another possibility in the
etiology of agranulocytosis.

Hart (45) 1 in 1927, suggested

a familial tendency when he observed agranulocytosis in two
sisters age 32 and 42.

Harkins (43) reviewed 150 oases

from the literature, in 1931, and ma.de this statement:
•one element in agranulocytio angina may be a constitutional
defect of the bone marrow.• Rosenthal (103), in 1930, from
the fifteen cases he had observed and·the others he had
reviewed, concluded that he was inclined to the idea that
agranulooytosis was a clinical entity, •related in some
instances to a constitutional hypoplasia of the leukopoietic
system; in other oases it may be a result of transitory
hypoplasia• •. Beck (3) stated that congenital. granulopoietic insufficiency seemed to have been proved in sane Qases,
but that the granulopoietic tissue in most of these patients
had, so far as was known, functioned normally for many years.
The cyclic and recurring nature, mentioned previously, of
,,,,,,....

some of the cases is ha.rd to explain on the basis of a. con-
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genital lesion.

Blumer (8) dismissed the possibility of

a congenital anomaly with the following statement: "The
same patient has reacted with the usual leukooytosis and
granulcytosis to one attack of an infection and has shown
a neutropenic and leukopenic reaction to another attack.•
Beck (3) concluded:

1

1hether certain patients have a con-

s,i tutional and abnormal functionally limited bone marrow
for making blood is as yet a theoretical 'IUestion. 1
Endoc~ine

Disturbances.-- The possible etiological im-

portance of an endocrine disturbance in agranulooytosis was
suggested by Thompson (134) in 1934.

This author made a

study of forty cases of the disease and found that in seventeen out of eighteen women, the onset of the subjective symptoms of agranulocytosis occurred within one or two days of
the menstl'U&l period.

In six of those patients, one or more

recurrences were seen, each appearing at the same time as
oatamenia.

Two patients who had had attacta previously were

followed with blood counts through a menstrual period and
a definite neutropenia occurred without subjective symptoms
a few days before cata.menia.

Thus, it seemed possible to

Thompson that in some cases of agranulocytosis, there was a
relationship between the hormones associated with menstruation and the neutropenio episodes.
son (57) and

~is

In the same year, Jack-

oo-workers reported the case of a women,

age 30, who bad four typical attacks of agranulocytosis in

30

two preceding years.

Her relapses had occurred in each

case with the onset of each menstrual period.

Oloae obser-

vation of the blood picture revealed that with the onset of
each menstrual period, the total number of polymorphonuclear neutrophils fell precipitantly, only to rise again.to
approximately the previous level.

With each oatamenia the

fall in the count became greater and subsequent recovery
less satisfactory.

The authors felt that there was a de-

finite •temporal relationship• between the menstrual cycle
and the intensity of the leukopenia.

It is interesting to

note that a different possible endocrine relationship was
observed by Oorey and Britton, in 1932, (17) in their study
of the blood cellular changes in adrenal

insuf~ietency.

They found that an agranulopenic syndrome was produced in
adrenaleotomized cats.

Hubble (48) suggested that glandular

dysfunction may play a role in producing the disease and ·
stated that bone marrow depression might be caused by a
pituitary insufficiency or granulopenia by cortical dysfunction.

Baldridge and Needles (2) were also of the opin-

ion that endocrine disturbance might possibly have a causal
relationship to agranulocytos1s.

Generally speaking, however,

the great volume of medical literature on this disease produces little evidence that endocrines are of primary importance in the etiology.
Itiologio Importance of Drug Therapy.-- Chemical poisoning of the hematopoietic system is well known, but usually
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drugs do not have an affinity for just the granulopoiet1c
tissue.

Farley (32) reviewed from the literature, in 1930,

thirty-nine oases in which the function of the bone marrow
was depressed following the use of various preparations of
arsphenamine.

The symptoms varied from those of purpura

hemorrhagic& to those of severe aplastio anemia and agranulocytosis, depending on whether the principal effect was on
the granulopoietic, megaltaryopoietic or erythropoietic tissues, or on all of these combined.

In 1931, R. R. Kracke (65)

made the first observation of the possible relationship between

agran~looytosis

and drugs containing the benzene ring.

He reported the case of a 44 year old woman who gave a history of using large amounts of coal tar derivatives during
the previous three years.

He said:

8

8inoe it is known

that benzene is a powerful leukocyte depressant, and that
coa.l tar derivatives are for the most part altered benzene
rings, the possible association should be considered.•

He

added, significantly, that coal tar derivatives have had
their widest usage since the world war.

Dodd and Wilkinson

(29) showed, in 1938, that arsenioals would depress the
leukocyte count.

Talley and Griffith (122), in 1930, re-

ported one of the few cases of agranulocytosis that have
been reported in negroes as following araphenamine.

Kracke,

(. :(96), in 1932, admitted that arsenioal preparations

should be considered as possible etiological factors until
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definitely ruled out.

He stated that Benzene, however,

was the only chemical that has been shown for many yea.rs
to be capable of producing a marked depression of the
leukocyte count to the point of complete agranulocytosis.
He stated; •Therefore it is the outstanding agent that
should be considered as causative of agranulooytoeis.•
(66)

Kracke/found that one of the first observations of
the toxic effect of benzene on the myeloblastic tissues
was that of Selling,

i~

1910, who observed three young

girls who had been working in a rubber factory where
they had been exposed to benzene fumes and then entered
Johns· Hopkins Hospital.

w~th

a clinical picture similar

to agranulocytosis complicated by purpura and hemorrhages.

Two of these patients died and the bone marrow

was found to be hypopl'astio.
of these cases

W!l1'8

The interesting features

the early ohronioity of snaptoms,

followed by sudden loss of neutrophils and rapid death.
One of .the patients had long before quit her work, which
could be interpreted as illustrative of the cumulative
and delayed effect of the chemicals on the hematopietic
tissues.

Selling (112) followed this observation by ex-

perimental studies on rabbits.

He injected benzene sub-

cutaneously in rabbits and succeeded in producing a
leukopenia down to 200 cells per cubic millimewer.

He

concluded that benzene destroyed white cells of the oir-
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culating blood and •parenchymal cells of the hematopoietio system", but that the circulating erythrocytes
were little affected.

Winternitz and Hirschfelder

(130) showed that a pneumonia exudate in benzene treated rabbits contained erythrocytes, fibrin, and endothelial cells but not neutrophiles.

Hektoen in 1916,

(46) concluded that resistance of benzene treated
animals was decreased by loss of neutrophiles, "Reduction
in antibodies and reduction in phagocytic activity of
leukocytes present•.
this out.

His experiments appeared to bear

Weiskotten and his associates, (129) in their

experiments to determine the normal life span of the
neutrophile in a rabbit, did a great amount of work on
the action of benzene in the animal organism.

They

showed that benzene produced an aplasia of the myelocytic
tissues, a marked granulopenia, and that the life span of
the rabbit neutrophile was about four days.

From these

reports it seems that the ability of benzene to produce
a reduction of neutrophiles with resulting death has been
well demonstrated in both man and expertmental animals.
There are those, however, who believe that the
picture presented by benzene poisoning and that presented
by agranulocytosis is not the same.

Beck (3) states

that benzene usually does not produce typical agranulocytosis, but a depression of all the bone marrow elements,
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so that anemia, purpura and sometimes methemoglobinemia,
as well as leukopenia and neutropenia, ane produced.
However, Kracke, (66) was of the opinion that the chief
action of benzene was on the myeloblastissues, and that
it could be administered in such dosage to produce marked

granulopenia with no apparent effects on either the
erythrocytes or platelets.

Therefore, in 1932, be conduct-

ed a group of experiments to prove his point, with the following conclusions:

(1) Subcutaneous injections of ben-

zene and olive oil, if given in sufficient small doses, so
as not to affect the erythroblastic

tia~ues,

the development of clinical agranulocytosis.

resulted in
The smaller

the dose, the more selective became the affinity for the
myelocytio tissues.

(a) The intravenous injection of ben-

zene even in small doses resulted in the immediate death
of the animal, "so it is probable that oxidation products
of benzene are directly responsible for its leukocyte
depressing properties•.

A marked leukopenia was produced

by the subcutaneous injection of ortho-exybenzoic acid
and by the intravenous injection of hydro-quinone.
tion products.)

(oxida-

(3) He was unable to depress the leukocyte

count in animals with: aminophrine, phenacetine, peragla,
dial;; resoroinol, pllrocatechin, orthocresol, metacresol,
paraoresol, phenol, pa.ra-oxybenzoic acid, meta-oxybenzoio
acid, or 50 per cent alcohol.

J'ollowing theae experiments,
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Iraoke concluded:

11

The etiology of agranulocytosis is

unknown but the benzene ring must be strongly considered.•
In the same paper, he reported that eight of the nine
patients w1 th agranulocytosis that he had seen had taken
drugs of the coal tar series prior to the onset of their
illness.

rollowing this report by Kracke, interest in

agranulocytosia soon began to center about the role of
certain drugs as etiologic factors in the causation of
the disease.
In October of 1935, Madison and Squier (77) reported
before the Central Society of Clinical Research that 8 the
increased incidence of primary granulocytopenia has paralleled the increase in use of drugs containing a barbiturate combined with amidopyrine•.

In a later article, (78)

these same authors reported that in 1931 they observed a
case which suddenly took a turn to the worse w1 th abrupt
decrease in granulocytes.

They found that the patient had.

been given a sedative dose of a barbituric acid derivative
on the preceding evening.

The drug was withdrawn and not

repeated and the patient recovered.

!hey later discovered ,

that immediately before the onset of the illness, the
patient had taken allonal (allyisopropyl barbituric acid
with amidopyrine) and for some time previously had been in
the bavit'of taking that drug frequently.

Soon after they

saw a woman who had had acute cholecystitis and was treated
by rest, diet, and two allonal tablets each nite for a
period of two weeks.

At the end of that time blood examina-

tion revealed the presence of only 1,200 white blood cells
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with a complete absence of granulocytes •. It was thee two
oases that so emphasized in the minds of lladison and lquier
the importance of drugs in this disease that they studied
the relationship in all oases seen subsequently.

Since

these two oases, thes authors reported, in 1934, that they
had treated twelve more.

In each of the fourteen oases

there was a definite history of the taking of amidopyrine
in combination with a barbiturate, amidopyrine alone, or
in one instance in combination with other drugs, immediately prior to the clinical discovery of the agranulocytosis.
Amidopyrine

w~th

a barbiturate had been used in seven of

the cases, amidopyrine alone in six, and a.midopyrine in
combination with other drugs in one.

They stated:

1

The

mortality in a group of six patients who continued the use
of drugs containing amidopyrine was one hundred per cent.
In a group of eight patients who did not continue the use
of these drugs, only two died, and both of these in the
initial attack.•

To obtain further evidence of the ability

of these drugs to depress the granulocytic tissue,. drugs
suspected of etiologic relationship were given to each of.
two patients who had clinically recovered from acute agranulocytosis.

The first patient, a man aged 40, who eighteen

months previously had had his initial attack following the
use of allonal and who had had a normal granulocyte count
for ten months, was given five grains of &$idopyrine.

In
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three hours he had a chill with return of symptoms of the
acute illness and in twelve hours the granulocytes had almost completely

die~ppeared

from the peripheral blood. The

second patient, a women, responded

~1th

similar results

after the administration of amytal and amidopyrine;. Amytal
alone was tried in the latter case but failed to produce the
effect.

Unaware of

~aoke's

(66) experiments with these

drugs on rabbits, lladison and Squier (78) attempted similar
ones.

One rabbit was given allonal by mouth in relativel1

large doses.

There was an abrupt drop in granulocytes and

the rabbit died on the thirtieth day.

Preceding death

there was complete absence of granulocytes in the peripher-

al. blood.

Seventeen other rabbits were given allonal or

amidopyrine~~

but they failed to show any marked change in

the blood picture.

These authors, therefore, concluded:

•we believe that, am1dopyr1nealone or in combination with
a barbttutio acid is capable of producing primary granulocytopenia in certain individuals who have developed
sensitivity to the drug.

We believe that the appearance

of primary granulooytopenia f ollo1fing the use of such drugs
may be the result of an allergic or anaphylactoid drug reaction.•
In 1934, Kracke and Parker (68) stated that they
found agranulooytosis was more prevalent among physicians
and thetr relatives, nurses, hospital employees, and
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members of allied professions, than in any other group in the
United States.

The fact that such drugs as amidopyrine

was especially available to this group seemed especially
significant to these writers.

In the same paper, they

presented eleven cases in which the patients were addicted
to the use of prescriptions or tablets containing amidopyrine (peralga tablets), phenacetine, acetanilid, aspirin,
eaffiene, empirin compound, allonal, or pyramidon.

Rawls,

(95) in 1934, stated that amidopyrine had been used extensively in the arthritis clinic of the New York Polyclinic
Kedical School and Hospital.

Two patients in this clinin

developed neutropenia while taking the drug.
fatal

One case was

The other patient returned to normal nine days after

amidopyrine was omitted, without any other form of treatment.

After a period of rest the drug was resumed and the

neutropenia recurred.

~his

time pentnucleotide therapy

and omission of the amidopyrine brought the blood to normal
in eight days.
Watkins (128), at the Kayo Clinic, reported 32 cases
of agranulocytosis.

Twenty-four of his patients had taken

ami.dopyrine or barbital derivatives.

Watkins concluded:

•1 do not feel that these cases prove that amidopyrine, or
derivatives of barbituric acid are etiologic factors in
producing agranulocytosis, but I do tielieve that there is
a possibility that certain individuals have an 1d1osyncracy
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to the drugs, which is manifested by agranulocytosis.
Randall (94) reported in 1934 the case of a twentyfive year old woman house physician who developed an
aoute and alarming leukopenia·following the use of
barbiturates and amidopyrine

1

may therefore occur only

in those individuals who are unusually susceptible to
the benzene chain. 1

Hoffman and his associates (47)

reported that in twelve of their fourteen cases of'
agranulocytosis a history was obtained of the taking
of some form of amidopyrine.
were fatal.

Thirteen of their cases

They explained that the common factor in

amidopyrine, benzene, arsphenamine, dinitrophenol, orthooxybenzoic acid, and hydroquinone,

11

all of which have

produced neutropenia experimentally or clinically,• is the
benzene ring.

"Whether", they wrote,

11

The latter is the

actual toxic agent in the production of neutropenia needs
further experimentation.

Our work points to amidopyrine

as having a definite effect on myeloblastic tissue similar
in man and rabbits.•
rine,

a.a

They gave rabbits doses of amidopy-

to 0.9 grams per kilogram, by mouth.

An almost

immediate leukocytosis occurred which was followed by a
depression of the white cell count.

In some of the rabbits

the polymorphonuclears were as low as eight per cent and
in all they were twenty per cent or under.
The fact that a person ingests a certain drug immediately
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before the onset of a disease is sugge.stive but not conclusive evidence that it is the cause of the condition.
The strongest evidence of this view, however, lies in such
cases as those reported by Kadison and Squier (78), Sturgis
and Isaacs (120), and Plum (92) who produced leukopenia in
patients who had. recovered from agranulocytosis promptly
after small doses of amidopyrine were

administered~

The relationship between amidophyrine and agranulocytosis has been studied by the Council on Pharmacy and
Chemistry of the American Medical Association (98) with
the conclusion that •as far as can be learned from the
evidence at band there can be no question that amidopyrine
is very important in the production of granulocytopenia.
It appears that barbiturates alone have little or nothing
to do with the condition.•

They advised,

1

Tbe indiscrimi-

nate and unnecessary administration of amidopyrine, and
the self administration by the public is certainly dangerous and should be discouraged.•

Plum (92) reviewed com-

prehensively the relatinn of amidopyrine to agranulocytosis
and stated, in 1935, that in a yea:r and one-half 128 cases
had been reported in which the disease developed after
therapeutic doses of amidpyrine.

Sturgis (121) emphasized

that this drug is not the sole cause of the condition and
Jackson (56), in 1934, reported a whole series of cases in
which there was definitely no history of such therapy.

Of
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course it is possible that in some of the oases in which
the patient reported that he had not taken amidopyrine as
such, he may have ta.ken it in combination with a barbiturate or some other drug under a trade name.
Kracke and Parker (69) wrote in 1935 a very comprehensive article on the etiology of agranulocytosis and
concluded that a great deal of evidence had been accumulated which indicated that the administraction aminopyrine
alone or in combination with one of the barbiturates was
responsible for the disease in a large number of patients.
They emphasized that it is almost impossible to obtain an
accurate history as to the ingestion of drugs after a
patient is dead.

They cited examples which

illust~ate

how

difficult it may be to secure a reliable history even from
a living patient and concluded that a •negative drug history is a worthless one."
In his paper in 1935, Gordon (41) was not in accord
with the more prevalent view that aminopyrine was an important factor in the production of agranulocytosis.

Af-

ter questioning 59 patients, he concluded that in only one
case could any therapeutic agent have related to the etiology of the disease.

In his opinion a number of factors

may be responsible for the disease, but he considered that
its absolute etiology still had not been recorded in the
literature.

Jackson (54),in 1935, wrote that aminopyrine

had an important etiologic significance in some cases,
but he expressed the opinion that conclusive evidence
had not demonstrated that it was the sole or even the
major cause of the disease.

In urging that caution be

used in accepting this drug as an important cause of the
agranulocytic state, he stated, in regard to its etiologic relationship to the disease, that some pat·ients recover even though the a.minopyriµe therapy is continued;
and that in other patients there was no evidence to indicate that the drug was taken prior to the attack.

He

has observed patients who took aminopyrine and became ill
with the disease, but despite the fact that the drug was
discontinued one or more relapses occurred.

In other pa-

tients, in whom the attack was precipitated by aminopyrine,
there had been no evidence that after recovery they continued to be sensitive to it.

He stated that it had been

suggested that the incidence of the disease was becoming
less, and that this had been attributed to the withdrawal
of the drug from the market, and yet he found that ·the
sales of aminopyrine had actually increased in the six
months prior to the time his paper was written.
Squier and Madison's (116) article, in 1935, presented observation on two patients which showed the effect
on the granulocytes in the peripheral blood of ·ten grains
of amytal compound (amytal with aminopyrine), five grains
of a.minopyrine alone, and the application of a ten per
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oent solution of the latter drug to the unbroken skin.
A significant granulopenia developed following the administration of the foregoing drugs, but there was no
important change in the white blood cell count when amytal
alone was given.

They concluded that.the oause of the

disease was an •allergic response to certain drugs• rather
than a

1

heightened pharmaceutic or physiologic response.•

Iastlin (63) bas made the observation that there must be
a variability of susceptibility in "sensitive• persons if
aminopyrine plays an important etiologic role in this
disease.

He reported the case of a patient who bad taken

this drug for years on account of insomnia.

A marked

granulopenia developed (800 white blood cells per oubic
millimeter), but reoovery followed despite the daily administration of amytaJ. and aminopyrine and of an allylisopropyl barbituric acid with aminopyrine.

The granulo-

penia reourred, however, and the drugs were withheld.
After a temporary recovery the disease again progressed
and terminated fatally.
Limarzi and Kurphy (73) reported a case, in 1935, of
a young woman, age 24, who had four recurring attaoks of
agranulocytosis over a period of about two a.nd one-half
years.

She had taken from fifteen to twenty grains of

aminopyrine, with or without aoetylsalicylio aoid, each
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week for the previous four years and yet showed no clinical evidence of agranulocytosis in the interim between the
attacks.

furthermore, during the last attack, at.which

time the leukocyte count fell to 1700 per cubic millimeter, with twelve per cent polymorphonuclear
a total of 370 grains of aminpyrine was given.

neutro~hils,

Despite

I

this, the blood returned to normal, and the patient made
a complete recovery.

0n the basis of this case, these

writers believe a patient •may become specifically susceptible from which a selective toxic action on the bone
marrow may arise.•

They made a skin patch test in this

case, but it was found to be negative.
Stenn (117), in 1935, was unable to produce the disease in guinea-pigs, rabbits or monkeys when aminopyrine
was given orally, subcutaneously, intraperitoneally and
intravenously.

He also was unable to produce the disease

when the drug was injected into animals in which an attempt
had been ma.de to sensitize them to it.

He used a total

of 120 animals in his experiments and concluded that there
was no evidence that agranulocytosis could be produced in
animals by aminopyrine under the following circumstances:
(1) 'I.hen there was severe anemia as a result of bleeding;
(2) after the

1

bone marrow had been previously injured by

the administraotion of benzene and olive oil 1 ; after the
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animals had been infected for one m,nth with Bacillus
subtilis, Streptococcus viridans, and Salmonella suipestifer, and (4) after a complete fast of five days.
Similarly, Kunde and his co-workers, (70) in the same
year, were unable to diminish the number leukocytes
in the circulating blood of normal rabbits by the administration of Oibalgine (aminopyrine and diallyl malonyl urea) orally in large doses for seventeen consecutive days.
rabbi ts with

They also studied the effect of this drug on
11

sniffles" or a

11

certain gastro-intestinal

inf ection 11 inwhcih there is normally a marked leukooytosis.

This leukocytosis was not depressed by administra-

tion of the drug for seventeen to thirty days.

Smith and

Ma.ck {115) likewise were unable to produce a.granulocytosis
although they did produce some degree of leukopenia in e5perimenta.l animals.

Working on the )ypothesis that a de-

ficient diet plus the toxic effect of drugs was of possible
etiologic importance, these men tested the action of amytal
and a.midopyrine on the blood picture of twenty-six, sixty
day old albino rats weakened by a deficient diet.

They .

found that the white blood count was reduced approximately
fifty per cent but that the differential counts showed no
significmt reduction of granulocytes.

A control grcup of

rats received the same deficient diet but no drugs and
their blood showed no change in the white cell count.
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Climenko (16) , in 1935,

s~udied

the inhibiting

effect of aminopyrine, antipyrine, alpha-dinitrophenol,
phenylhydrazine hydrochloride, catechol and orthoquinone
on the leultocytosis which is ordinarily produced in the
rabbit by the parenteral injection of nucleic acid.

He

found that the intramuscular injection of five milligrams
of nucleic acid per kilogram of body weight produced a
maximum white blood cell count of 15,000 in four hours,
34 per cent of the cells being polymorphonuclear neutrophils.
After the rabbit had received 0.2 grams of aminopyrine orally for eighteen days, a similar dose of nucleic acid was
given intramuscularly.

No .significant response was evoked

in the white blood cell count.

'lbe other drugs mentioned

produced atmilar inhibitions to leukooytosis.
The theory that aminopyrine may be responsible for
agranulocytosis in certain susceptible persons has received
fairly widespread acceptance.

It is known, however, that

many persons may take large amounts of the drug without
producing the syndrome.

Nor can it be said that it is the

sole etiologic agent, as other drugs, such as dinitrophenol,
apparently have been responsible for its production in some
instances.

In 1934, .Hoffman and his associates (47) report-

ed the first case of dinitrophenol causing agranulocytosis
in a patient who had taken the drug for
for a period of two weeks.

~eduction

She recovered.

purposes

Bohn, (10) in

the .same year, described a case which deviloped in a patient after the ingestion of 21.8 grams of

dinitrophenol
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sodium over a period of four months.

Dameahek and Gar-

gill (18) reported two cases of agranulocytosis following
the use of dinitrophenol therapy.
Although all observers are not in accord, Rawls (95)
olained, in 1936, that sufficient data have been accumulated
to indicate that aminopyrine bears some causal relationship to agranulooytosis.

He administered over 100,000

tablets of aminopyrine or aminopyrine mixed with magnesium
carbonate to 400 patients in clinic or in private practice.
In four (one per cent) of these patients agranulocytosia
developed, and three died of it.

Exclusive of the four

patients, there were no significant changes in the white
blood cell picture of 100 patients who received an average
daily dose of about thirteen grains for a mean interval of
approximately eighty-four days.

Rawls concluded that

aminopyrine does not produce hematologic changes •except in
isolated oases, in which there probably is an idiosyncraoy
to it.•
The blood of one hundred patients with various diseases,
chiefly rheumatism and infections of the upper respiratory
tract, who were treated with salipyrine (combination of
salicylic acid and antipyrine) was studied by Nammaok and
Thorsteinson. (85)

They explained that antipyrine contain-

ed a benzene ring and was closely related in chemical structure to aminopyrine.

Their repeated examinations of the

blood of the patients failed to show a significant change
in the total white blood count or in the percentage of
neutrophila, nor was there any change of importance in the
Schilling count.

From their experience and a review of the

literature, the authors concluded: "Heutropenia in connection with drugs containing the benzene ring probably depends on individual idiosynoraoy to this type of drug.•
Witte (131), in 1936, aptly stated that the evidence
incriminating aminopyrine as the chief cause of agranulooytosis may be classified as ciroumstantional, experimental and direct.

Circumstantional evidence includes the

many reports in which a history of the taking of the drug
prior to illness was obtained.

Experimental evidence lies

in the production of the disease in laboratory animals by
the administration of aminopyrine.

Direct evidence is found

in those cases which have recovered from an attack thought
due to the drug, and which another attack has been precipitated by administration of the drug.

Witt mentioned in

the same paper that in England the 'Poisons List Confirmation Order•, which went into force on May l, 1936, makes
it necessary to have a written order before aminopyrine can

be supplied.
Parker and Kracke, (87) in attempting to produce the
disease experimentally, cause leukopenia of •usually less
than 1,000 leUkocytes " in rabbits by the subcutaneous injection of benzene in olive oil and showed that these animals had a marked depletion of the biologically active or
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-

reduced glutathione in the bonemarrow and the blood.

They

suggested that a depletion of this form of glutathione in
human blood and bone marrow may lead to various leukopenic
states.
Benjamin and Biederman ( 4) reported observations on the
blood of a patient after the oral administration of 10
grains of Novaldin, a drug which is closely related to aminopyrine.

This preparation was given to a woman who pre-

viously had had several attaek·s of agranulocytoeis after the
ingestion of aminopyrine.

Eight hours after the drug was

given subjective symptoms appeared and within twenty-four
hours the white cell count had fallen from 5,300 to 2,800
and the polymorphonuclear neutrophil cells had been reduced
from 73 to 46 per cent.

Intraoutaneous, patch and passive

transfer tests with Novaldin gave negative results.

The

authors concluded that this drug may "produce the same deleterious effects as aminopyrlne on the hematopoiet1c system".

Klumpp (64) substantiated this view •hen he reported

the oases of a patient in whom agranulocytosis developed
after the use of N0 valdin for headache.

The patient expir-

ed after a fulminating illness of six days, during which
time the leukocyte count fell to 150 with a complete absence of polymorphonuclears.

In attempting to answer the

question, "Is there a safe method for administration of
aminopyrine and its derivatives?" Klump concluded, "The
abrupt onset without warning and fulminating course of
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this case, and others I have seen, lead inescapably to the
same co clusion that there is o entirely safe method of adminstering aminopyrine.•
Goldman and Baber (39) reviewed the literature concerning the relation between dinitrophenol and granulopenia and
added the report of a.n a44ttional case which they had observed.

Their patient, a girl of 13 years, had taken 0.1

grams of dinitrophenol daily for forty-six days.

Wea~nese,

malaise, feverishness, sore thorat and vomiting appeared and
she suddenly became acutely 111: and irrational.

The white

blood cell count was ?00 with 100 per cent lymphocytes. The
patient died and no changes were found in the granulopoietic
system at autopsy.
to this case:

1

Goldman and Haber concluded in reference

The fatality can be attributed either to cumu-

lative toxicity or to an idiosynoracy to the drug. 0
Davis and Friasel (aa), in 193?, reported that they had
given aminopyrine daily to 'thirty-two patien1is for varying
periods up to three months without demonstrating any alterations inthe white blood cell count.

They also observed

patients who had used the drug for more than four years
without dangerous clinical symptoms.

Of fifty patients who

received cutaneous teats with aminopyrine, only one, who
was seuaitive to the drug, reacted positively.

However,

these writ.era did report that 1-n their aeries of twenty
eases of agranulooytosis, ten of the patients were known
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to aave ta.ken

aminopyri~e

or allied drugs.

Shapiro and

Lehman (113) reported that they observed a man in whom
agranulocytosis developed after he had taken cinchophen,

o.5

grams three times daily for about three weeks.

They

pointed out that cinchophen under "certain Conditions" aay
yield benzene or nitrophenol, either of which "can cause
a paralyzing effect on the bone marrow".

Dowds (30) re-

ported a fatal oases of a granulocytosis in apatient with
syphilis.

He concluded that intramuscular injections of a

bismuth preparation caused the condition, and he stated
specifically that aminopyrine was not a contributing factor.
Davis and Frissell (22) summarized the literature
regarding aminopyrine hypersensitivity and found discussions
of three theories to explain the role of aminopyrine i{ltoxi:oation in

~he

production of granulocytopenia; 1. All drugs

with the benzene nucleus, or the benzene nucleus in association with an amino group, are per se toxic, presumably to
the bone marrow. 2. Aminopyrine is semispecific for the bone
marrow and produces a direct intoxication of the leukopoietic tissue.

3. The hemopoietic changes are the result of an

allergic reaction.
Sulfanilamide, the remarkable drug which has proved to
be of so much value in the treatment of beta streptococcus
infections, gonorrhea, pneumonia, and other infections, is
not without its dangers to the blood.

These dangers include
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the deve1opmant of methemoglobinemia and cyanosis, acute
hemolytic anemia and now agranulocytosis. (67)

In a letter

written April 17, 1937, Plumer (93) described the case of
a woman of 54, suffering from subacute bacterial endocarditis of about five months duration.

Her blood culture was

positive for streptococcus virida.ns.

She was given one gram

of prontylin a day for four days, and 1.3 gra.me for thirtyone days, when it was discontinued because of nausea and
vomiting.

'l'hree days, thereafter, the white count had fallen

to 400, with no neutrophils; it rose the next day to 1600,
but extensive gangrenous infection of the mouth and pharynx
had already developed and death occurred on that day.

As

no other drugs were administered and no history could be
obtained that she had taken other drugs, Plumer concluded
that the agranulocytosis was due to prontylin.

Plumer'a

cases is the first reported in which agranulocytosis
has been attributed to sulfanilamide.

Three months later,

however, Young (132) reported agranulocytosis with fatal
outcome in a man suffering from acute rheumatism, who had
taken 3 grams of prontosil album for eithteen days. The day
before death the total white count was 1800 with no neutrophils.

A feature of the case was the failure of serial

leukocyte counts to give warning of the impending disaster.
The bone marrow shOled complete aplasiaat autopsy.

the only

benzene ring drug administered within twenty-four days of the
development of agranulocytosis was sulfantlamide.
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Less than a month after Young•s report, Model (82) reported
the case of a man of

ao,

suffering from a recurrence of

rheumatic fever. Three grams of .0 proseptasine• (para-aminobenzenesulphonamide) were
discontinued.

gi~en

for eighteen days and then

Two days later the leukocyte count was found

to be 600 per cubic millimeter.

In spite of blood trans-

fusions and pentnucleotides, death occurred the following
day.

~odel

said: dAlthough there is no proof that the agranu-

looytosis was due to the sulfanilamide, this case and Young's
case suggest the advisability of a daily leukocyte cCllnt in
cases in which this drug is given over long periods."
Borst (11) reported a case of a woman, age 61, being
treated for pyelocystitis.

She received 6 tablets (300 mg.

each) of prontosil flavum daily for nine days following which
her urological symptoms subsided and the drug was stopped.
About a week later, however, the symptoms reappeared and the
drug was again prescribed in the same dosage for a period
of eleven days after which the dosage was increased to 8
tablets daily.

A week later the patient complained of

general discomfort, difficutly in swallowing and had a
temperature of 102.2.

A blood count at that time showed

960 leukocytes per cubic millimeter with only one per oent
polymorphonuclears. The patient died that day.
cluded:

1

Borst con-

There can, I think, be no doubt about the close

connexion between the use of prontosil flavum. and the
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occurrence of a.granulocytosis in this case.•
Jennings and Southwell-Sander (60) observed agranulocytoais in a 39 year old woman who suffered from ulcerat1 ve colitis.

Sulfanilamide, 4.5 grams per day, had been

given for three weeks and discontinued because her
had disappeared.

sy~ptoms

Two days later evidence of agranulocyto-

sis began and increased inseverity for four days, when the
total whit count was less than 400, none of which were polymorphonuolear cells.

Under pentunucleotide therapy, there

was a rapid rise in the polymorphonuclear count and general
improvement and recovery.

1.his

is the first case of agranulo-

cytosis attributed to sulfanilamide in which recovery has
occurred.

Schwartz and his associates (111) in January of

1938, reported the case of aman of 33, treated for a penile
ulcer with sulfanilamide over a oeriod of twenty-one days,
during which time he took a total of 56.6 grams.

The typi-

cal symptoms of agranulocytosis, with a leukocyte count of
2000 and an absence of polymorphonuclear cells, developed.
Ihey attempted to stimulate leukopoiesis by Ell intravenous
injection of killed typhoid bacilli.

The temperature in-

creased but the leukocytes continued to drop to 800 with an
absence of granulooytes on the smear.
increasingly toxic and died.

The patient became

The authors stated that they

believed that sulfanilamide was the only drug that could be
directly incriminated beeause the patient was in good general
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health proir to receiving the drug and then , coincident
with the intensive a.dmintstration of it, granulocytopenia
developed abruptly.

They emphasized thatsulfanilamide has

a multiplicity of serious toxic properties, particularly with
reference to the hemopoietic system and therefore that it
should be administered only under careful observation and
with frequent examinations of the blood.
Berg and Holtzman (5) reported a fatal attack of agranulocytosis in a man who' took 38 grams of sulfanilamide in
eleven days for acute gonorrhea.

They state:

1

If there is

any question as to whether sulfanilamide can induce the
granulocytopenio

st~te,

this third reported fatal case adds

it weight· to the belief that the relationship is acuually
causal. 11

Jones and Killer (61). reported, in November, 1938,

a oases of a man who had taken sulfanilamide for eight days
following which he developed a fever and generalized aching pains. ': Two attempts to resume therapy were followed by
a return of symptoms, the last time accompanied by severe
neutropenia, with a total white blood cell count of 2,300
of which only five per cent were neutrophils.

The authors

recorded the sulfanilamide concentration in the blood in
relationship to the leukocyte count and concluded that there
was apparently an "increasing susceptibility .to the drug".
Allen and Short 4escribed a case in July, 1938, in which
an eighteen year old school girl was treated by sulfanila.mide
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therapy for a Bartholin's abscess, presumably due to the
gonoooceus.

The patient made a spontaneous recovery.

had received no other drugs

1

She

whivh might have been indicted

as possible causes of granulocytopenia, so that aulfan1lam1de can be considered, at least presumptively, as the cause
of her agranulocytosis.•
It will be noted that these cases have all been reported since April, 1937, and that the average age of the group
is about 37 years and over half of the oases were in young
adults, only three of which were females.

!n every instance

rather large amounts of the sulfanilamide eJ?.e administered
before the disease made its appearance.

Kracke (67) be-

lieves that this indicates that the mechanism of granulopoietio depression may be 41fferent from that following the
administration of a single dose of aminopyrine.
basis of his study of such cases, Kracke

On the

concluded~

•Sulfa-

nilamide should be added to the list of drugs that are
capable of producint agranulooytosis.•

He felt that because

of the increasing use of this drug there will probably be
an increasing number of cases of the disease following its
administration.

He said:

1

It is reasonable to assume that

the market will shortly.become flooded with patented remedies containing sulfanilamide and th t the dangers of agranulooytoais will become more accentuat
In a study of the relation of d

g therapy to neutro-
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pen1c states, Xracke (67), in October, 1938, drew attention
to a chart whtmh he took from Plum's investigation of
agranulocytos1s in Denmark.

The chart reveals that the

consumption of aminopyrine in Denmark before the disease
made its appearance was practically nil, and that there was
a gradual increase in the use of aminopyrine paralleling
the increasing number of cases of agranulocytosis, the
peak being reached in 1934.

At that time the use of the drug

was practically abandoned, and the·d1sease practically disappeared.
Kracke (67) has compiled a list of drugs and preparations that are known to be capable of producing agranulooytosis.

They are presented in tbe table below:

*(A)Preparations that should be used with caution
because they may depress the leukooytea.
Aminol
Barb-Amid
Allonal
Ami4on1ne
Benzedo Comp.
Am-Phen-Al
Alphebin
Amidophen
Cibalgine
Ampydin
Amarbital
Amidos
Oompral
Amidotal Comp. Amytal Comp.
Amidol
Bar amid
Cronal
Amido-Neonal Amifein
Neurodyne
Phenopyrine
Dymen
&ardon
!yram.idon
Dys co
Lumodrin
Nod
Optalidon
Pyraminol
Eumid
Midol
Per alga
Seequit
Gynalgos
Myl1n
Phan-am.idol
Yeast-Vite
Hexin
Neonal Comp.
(B)Drugs Known to Produee Depression o:t the Marrow: ·
Dinitrophenol
.Antipyrine
Arsphenamine
Sulf anilamide
Novaldine
Sedordmid
*Preparations listed under (A) contain aminopyrine.
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Endogenou• Disturbances in the Bone Karrow.-- According to Beoj,(3) two different processes must be considered
concerning the mechanism to maintain

production and des-

truction of granulocytes at a constant level: 1. The mechanism of delivery of cells to the circulation.
mechanism of maturation.

~1 a.

The

As far back as 1927, Xastlin,(62)

in discussing the pathogenesis of agranulooytosia, said:
11

The hypoplasia of the granular cells is not a term1ilalJ.

event and the decrease of the cells in the blood stream
appears to be due to failure of development of the cells
in the bone marrowff·. The early writers nearly all believed
that the bone marrow in these cases was always aplastic.
Leon (74), who wrote one of the first papers on this subject, in 1923, stated thatthe bone marrow did not contain
leukocytes nor nyelocytes.

However, Buck (14), in 192l,

reported a case in which postmortem examination ef the
bone marrow revealed evidence of acute hematopoiesis with
cells normal in number and character and even myeloid
hyper plasia.

Kracke (66), in 1932, reported that he

~ad

studied the bone marrow reaoved during life from five
patients with agnanulocytosia and found

11

an apparent

cessation of activity of the myelocytic elements and in
some oases the complete absence of those elements•.
Dameshek and Ingall (19), and Baldridge and Needles (a)
were of the opinion that the bone marrow was not aplastic.

59

Thus the literature presented a picture of chaos as far as
the pathology of the bone marrow and the pathogenesis of
the disease was concerned.

It remained for Fitz-Hugh and

Krumbbaar (36), inl932, to clarify the situation.

They

reported a oase in which myelocytes and myeloblasts were
found in the bone marrow at necropsy in more than normal
numbers.

The case was that of typical agranulocytosis,

clinically, and the antemortem white blood cell count was
200, all of which were lymphochtes.

Bases on these find-

ings and similar ones recorded in the literature, these
writers raised objection to the then current hypothesis
of •granulocytic aplasia• as constituting the primary
pathologic mechanism of the disease, and in its place they
proposed the

~Jpothesis

of •maturation arrest•.

The

following year, Fitz-Hugh and Comroe (35) reported that
necropsy studies bad shown in more than half of the cases
examined, by them, a plentiful supply in the leukopoietic
centers of the progenitors of the blood leukocytes.

They

pointed out that this virtual hyperplasia was in marked
contrast to the profound peripheral leukopenia characteristic of the disease, and nstrengthens the previous suggestion of an hypothesis of primary

1

maturation arrest•

rather than primary •aplasia' to aooount for the hematologic phenomena of the disease."
~tained

Thus these writers enter-

the opinion that •agra.nulocytie angina exists as a
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valid clinioopathologic entity in the same sense that pernicious anemia is accepted"•

They explained that it was

not many years ago that it was difficult to "defend the
nosologio purity• of pernicious anemia but that it is now
possible to exclude certain obscure pernicious-like anemias
from the category of pernicious anemia by virtue of their
failure to respond to adequate specific therapy.

They

concluded: "In a stmilar way agranulocytosis should be
viewed as a disease entity which awaits the discovery of a
specific therapy to stamp it with unmistakable validity.•
It was from these observations that the authors suggested
the name

1 pernicious

leukopenia 0 , which suggests certain

analagies between agran.ulooytosis and pernicious anemia.
Beck (3) stated that in typical cases of ~ranulocyto
sis there is a myeloic aplasia, and the part of the bone
marrow that manufactures the granular leukocytes has ceased to function, or neraly so.

She pointed out that the

life of the granular cells in the blood stream in normal
conditions of health is considered to be from three to five
days; therefore, when manufacture of the granulocytes ceases
and the supply of promyelocytes and metamyelocytes is exhausted, the granulocytes of the blood stream wculd totally
disappear in from three to five days after the exhaustion
of the supply•

Beck added that there was little evidence

that the granulooytes are abnormally destroyed in the blood
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stream and that the bulk of all evidence pointed to the
fact that the primary lesion in these cases, so far as
known, was in the granulopoietio areas of the bone marrow,
and that this condition preceded the clinical symptoms
and local infections.

Therefore, Beck was

dz~wn

to. the

same conclusion that was reached by Fitz-Hugh and Irumbhaar (36), relating to a •maturation factor•.

She said:

"It seems reasonable to suppose that the primary lesion is
not in the bone marrow but in the organ· or tissue which
gives rise to the substance (factor) that keeps maturation
of the granulocytes regulated to a normal level or regulated so that destruction and production are kept constant.•
In· the same paper,Beck (3) pointed out chat the textbook
4esentpt1ons of pernicious anemia could be made to apply
astonishingly well to this type of agranulocytosis, the
prinQipal alteration being the substitution of the granulopoietio for the erytbropoietio tissue.

Beck stated: "The

maturation factor for erythrocytes has been foune.

It now

remains to find a maturation factor for granulocytes•.
Similarly, Gordon (41) stated:

1

The cause of the disease

may be a deficiency of some substance that will correspond
to ventrioulin in pernicious anemia.•
Roberts and Iracke (101) have presented a logical
theory concerning the mechanism of the production of the
disease, as follows; First, there is the onset in the
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bone marrow with a failure of

myelocyt~c

function.

Thia

may be due to myelocytic aplas1a or cessation of maturation.

Second, after a few days there' is an onset in the

blood stream with a gradual dimtnution of the granulocytes
until the number is g reatly reduced or they completely
disappear.

Third, there is the clinical onset, with the

appearance of the characteristic symptoms.

rourth, with

a loss of protection, bacterial invasion begins and sixth,
recovery or death occurs.
In his review of the,present day findings and hypotheses of agranulocytosis in 1937, Thomas Fitz-Hugh (34)
showed some dissatisfaction with the theory be origtnally
introduced that a •maturation arrest• was the principal
underlying factor in the pathogenesis of the disease.
stated:

1

He

The sudden changes in the granulooyte count of

the peripheral blood (of •sensitized' individuals remaking contact with a drug) occur too rapidly to be mediated
by a •maturation arrest• mechanism.•

Such sudden changes

he has referred to as •granulocytoclastio phenomena•.

He

explained that Clarke's work on the changes of the capillary
endothelium might offer a possible mechanism for the sud.den
changes in the granulocyte count. (Clarke and Clarke (15)
showed by means of a glass rabbit's ear chamber, in which
they could observe the cells within the capillaries, that
minute stimuli of a mechanical, thermal or chemical nature
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resulted in changes of the endothelium which resulted in
the adhesion of the leukocytes to the capillary wall.)
•one might hypothesize•, concluded Fitz-Hugh, •several such
granulocytoclastic episodes might precede the final bone
marrow arrest which in turn initiates the usual clinical
syndrome.•
PATHOLOGY
In the previous section attempt was made to show that
in the earlier writings there was m.uoh disagreement as to
the pathologic picture of the bone marrow in agranulooytosis.

At the present time, however,

there~ts

quite general

agreement that the bone marrow changes are variable.
(12) has summed up this view as follows:

1

Boyd.

As a rule it

(the marrow) is aplastic and appears to be completely exhausted, as is seen in experimental benzol poismning.
others it is normal, and in still others it
plastic.•

may

In

be hyper-

Beck (3) stated that in practically all fatal

cases the bone marrow was degenerated to a great extent,
often licpid, and varied in color from red to straw.

This·

author also stated that there may ue areas of patchy
necrosis in the marrow and that normoblasts and megakaryooytea were present in their normal numbers, but the myelooytes and polymorphonuolear cells were absent or nearly
absent.

Howerer, in 1936, Darling, Parker and Jackson (20)

made an analysis of 25 typical cases of agranulocytosis
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and concluded that '· as Fitz-Hugh and Krumbhaar (35) first
suggested, in rapidly fatal oases the bone marrow shows
stem cell hyperplasia and myeloid anakmesis,(the wort thay
have given to maturation arrest)w1th01 t notable changes in
the red oellrseries and that as the survival of the patient
became longer the cells gradually and somewhat irregularly
gave way to plasma cells and lymphocytes.

They hypothe-

s1 zed that early in the disease there is a oompens.atory
increase of the number of normally occurring stem cells
(myeloblasts) in a vain effort to overcome the maturation
arrest and that in the latter stages these stem cells disappear and a coincident increase of lymphocytes and plasma
cells occurs.

They found that in the recovery stage there

was a rapid development of the stem cells into myelocytes,
metamrelecytes, and polymorphonuclear neutrophils.

These.

changes, in the authors• opinion, substantiate the previous
contention of other investigators that the condition in
the bone marrow is one of arrested maturation,
There is little mention made in the literature of the
pathology of agranulocytosis excepting that which refers to
the changes which occur in the bone marrow. ' the sharply
outlined necrotic lesions in the oral cavity and elsewhere,
according to Ordway and Gorham, ( 86) are

1

characterized:'by

a peculiar reactionlesa type of inflammation", that is, a
complete absence of polymorphonuelear leukocytes, and only
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-

a few lJmphocytes and plasma cells.

These authors pointed

out that such necrotic ulcerations may occur in varying
degree, in the mou.th, esophagus, intestinal tract, vulva,
vagina or skin.

Beck (3) s,tated that it is possible that

the lesions along the gastro-intestinal

~ract

are affected

by the usual bacterial inhabitants which gained entrance
tothe tissues as a result of the removal of the protective
mechanism of the granular leukocytes.
The enlargement of the spleen in some cases has been
found to be due to a great increase in the retioulo-endothelial cells, which outnumber the lymphoid cells.

The

lymph follicles are small and atrophic, and there are no
young cells or lymphoblasts in the germinal centers, only
mature lymphocytes.
show cloudy swelling.

The liver may be somewhat enlarged and
Microscopically, some oases have

shown fatty degeneration, and occasionally small multiple
foci of necrosis. The submaxillary, cervical, peribronchial and mesenteric lymph nodes are in general enlarged,
and they sometimes contain hemorrhages.

Microscopic ex-

amination reveals atrophy of the lymph follicles; there
are no young lymphocytes in the germinal centers, only
mature lymphocytes being present.

There is a proliferation

of the reticulo-endothelial cells. (3)

SYMPTOMS, SIGNS, AND BLOOD PICTURE
The clinical symptoms, -signs, and blood picture of
agranulocytosis have been reviewed by roaq authors in the
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literat\Jre, each presenting almost identical descriptions,
the one phase of this condition in which there is, apparently, quite

wide-spread agreement.

For that reason only

brief consideration will be given in this paper.
(125) description is typical;

~e

onset of the acute case

is abrupt, usually during good health.
are fever and prostration.

Thompson's

The first symptoms

The temperature rises within

a few hours to 104 to 105 degrees; malaise rapidly progresses to exhaustion.

During the first one or two days these

are often the only symptoms. A severe infection is suspected, but there is no subjective or objective evidence of
localization.

A diagnosis can be made at this stage only

by the finding of the extreme neutropenia which has existed from the onset.

Jaundice may or may not be present.

The early writers stressed this finding as appearing in the
majority of oases, but modern writers find that it is rare
in typical oases. The end of the second day usually marks
the appearance of the gangrenous lesions of the gums and
throat.

These begin as small discrete patches of edematous

redness.

They spread rapidly, the centers become ulcerated

and necrotic, and they tend to coalesce into irregularly
shaped areas of gangrene covered by a thick, tenacious,
grayish white membrane; and surrounded by a similar raised, spreading, red margin.
in the rectum and vagina.

Similar ulcerations may appear
As a rule there is relatively
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little reaction in the neighborhood of these lesions, the
contiguous lymph nodes are only slightly enlarged and a.re
rarely tender.

The spleen is not enlarged as a rule. (125)

Jackson and parker (58) stated that the finding of an enlarged spleen should indicate a leukemia instead of agranulooytosis.

Kastlin (62) found the spleen palpable in 33

per cent of the oases.
Although gangrenous stomatitis is by far the most
frequent lesion, the infection may appear in various other
places and assume various forms. Occasionally the lungs
are the site of an extensive bronchopnelimonta; acute pyelitis with pyelonephritis has been seen.

Several instances

of gangrenous vaginitis and endometritis have been reported, as have cases of proctitis and perirectal abscess.
Abscesses tend to develop during convalesence.

'.L'he chronic

form of the disease is characterized by a persistent leukopenia of from
phils.

a,ooo

to 4,000 with 25 to 50 per cent neutro-

There is moderate malaise and weakness of a chron-

ic type.

There is no angina or ulcerations except follow-

ing a period of extreme leukopenia and neutropenia when
an acute attack is ushered in. (125)
The typical agranulocytic type of blood picture presents few difficulties in diagnosis. There is a marked
decrease in the total number of white blood cells, the
counts ranging usually from 1,000 to 3,000 per cubic millimeter; white counts as low as 150 to 300 are not at all
uncommon.

Examinations of the stained smear shows a great
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scarcity of white blood cells.

Kany low-power fields may

have to be examined before a single cell is found.

Of

the white cells that are seen, all, or nearly all, are
adult, mature, small lymphocytes.

A rare large lymphocyte

and an occasional monocyte may be encountered.

When com-

plete agra.nulocytosis exists, no polymorphonuclear leukocytes are found.

With the less severe degrees of depres-

sion, it is possible to find occasional granular cells,
rarely more that ten per cent of the total number.

The

polymorphonuolear leukocytes, when found, are almost invariably adult, mature cells with a nucleus of from three
to f1 ve lobes.

Eoxinophils are

forms of granulocytes.

a~sent

as are the young

(Thompson (125))

Concerning the erythrocyte count,Sturgis and his
associates (121) said:

1

ficant degree of anemia.-

There is rarely if ever a signiWhen this is present it usually

indicates that the leukopenia is associated withsome otber
disease.•

Jackson and Parker (58), however, pointed out

that since the disease is most frequently found in middleaged to older women, the finding of a moderate degree of
anemia would be of no great consequence.
'!'here is a controversial point in regard to the
blood picture as far as the platelets are concerned.

the

majority of observors agree that the number of platelets
is normal or

increased.

Others believe the number 1e
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reduced.

Roberts and Kracke (101) stressed that a hemorr-

hagic tendency was common in the disease, whereas most observors have stated this finding is rare.

Schult~

and

Jacobowitz, (110)in'l925, emphasized the absence of hemorrhagic diathesis and thrombopenia and the practically
normal erytb.ropoiesis as strict criteria for ·the diagnosis
of the disease.

Likewise,Jackson and Parker (58) stated

that cases showing reduced platelets and marked anemia are
probably acute leukemia or aplastic anemia.
PROGNOSIS
In the beginning the mortality of agranulocytosis was
reported as 100 per cent.

The first recovery from the dis-

ease was reported by Lauter,(71) in 1924, who reported the
case of a young woman with
stomatitis 11 •

11

agranulocytic tonsilitis and

In 1927, Kastlin (62) reviewed the forth-

three cases he found in the literature and discovered only
three recoveries or a mortality of about 94 per

cent~

Harkins, (43) in 1931, found twenty-seven recoveries had
been reported in the one hundred and fifty recorded cases,
the approxiamte mortality rate being 82 per cent.

Taussig

and Schnoebelen (123) reviewed three hundred and twentyeight oases and found that the mortality was 75 per cent.,
without special therapy and with miscellaneous forms of
treatment; 63 per cent with transfusions of blood, and 53
per cent with roentgen treatment.

Jackson and his co-

workers, (55) in 1933, reported a mortality of 30 per cent
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in fifty-four typical oases in which treatment consisted
of nucleotides.

From these various reports, it would seem

that the mortality rate has been steadily decreasing since
1927.

On the other band,

Fitz~Hugh

(34), in 1937, stated

that his present mortality was 75 per cent.

Similarly,

Ordway and Gorham, (86) in 1937, stated that the mortality
was "at least 75 per cent•.
Very few patients recover if the total count falls
below 1000. (3)

Kracke (65) reported one case which

showed a leukocyte count as low as 470 and recovered, only
to die in a second attack.

It is possible -that the appa-

rent decrease in mortality in some reports is due tottle
fact that closer observations of the blood picture have
cause some writers to include so-called "benign° or "chronic" forms in their statistics.

Ordway and Gorham (86)

have pointed out that recovery from the first attack, with
death in aseeond or third episode, may occur.

They state

that in general, the ,outlook will depend' -on the kind m d
degree of marrow injury, the degree of secondary infection,
and the general recuperative power of the bone marrow.
TREA'l'MEN'l'

There have been recorded many different suggestions
as to the proper treatment of agranulooytosis.

Kost

authors, however, believe that- a specific and entirely
satisfactory treatment has not been discovered.

Kany
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believe that recovery, when it does take plaoe, is spontaneous and not influenced by the type of treatment.

Ham-

burger (42) reported a oase in a patient with 1500 white
cells and two per cent neutrophils.

This patient recovered

in four weeks without any active treatment, and was still
well five years later.

In many cases in which recovery

occurred,several types of treatment were used, so that it
is impossible to draw decisive

conclusion~

as to the effi-

cacy of the measures that were used, or to say which, if
any, was responsible for the.cure.
Treatment of Local Lesions.-- The most frequent
complication of agranulocytosis is infection, local or
general.

The local lesions are most frequently found in

the mouth and throat.

All authors agree that the lesions

require careful and intensive treatment.

Babbit (1) stat-

ed, in 1930, that combined antiseptic and cauterizing
measures should be employed.

For a cauterizing measure,

he prefers the use of 25 per cent trichloracetic acid and
ten per cent neo-arsphenamine.

He reported recovery in the

case of a patient in which the leukocytes were down to
600 with a complete absence of granulocytes.

Hamburger (42)

advised the following for local trea'tlment: After nourishment, the mouth and throat are sprayed \11lith a saturated
solution of potassium chlorate.

Following the spraying,

each ulcerated area and the gums are swabbed with a solution
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of copper sulphate, 10 grains to the ounce.

This oral

treatment is given as often as five times a day, and
less frequently as improvement takes place.

It is ob-

vious that in the absence of granulocytes no frank abscesses will form but with the onset of recovery and the return
of these cells to the blood stream such lesions are not
uncommon.

Any abscesses that form, of course, should have ·

proper surgical incision and drainage.

Beck (3) empha-

sized the importance of refraining from any surgery in
these patients that can be possibly avoided.

She stated

that such a procedure may bring about sluughing of tissue,
as healing cannot take place.normally in the presence of·
leukopenia and neutropenia.
Miscellaneous Agents Used.-- The use of Neo-araphenamine, intravenously, was mentioned by MoQre a.nd Wieder,
(83), in 1925.

Rosenthal (103), in 1930, advised the use

of neo-arsphenamine and blood transfusions.

His series

at that time showed six recoveries in fifteen cases.
However, such treatment would certainly seem paradoxical
in the face of Farley's (32) finding of thirty-nine oases
recorded in which the function of the bone marrow was depressed following the use of various preparations of arsphenamine. Diphtheria antitoxin, intravenous merourochrome,
iron, arsenic, streptococcus sermn, typhoid vaccine, and
other forms of foreign protein, have all been tried without apparent success. (40)(114)

Intravenous injections

of gentian violet and acriflavine have veen tried with
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the idea that there was a blood steam infection. (3)
Roberts and Kracke, (lOl)in 1934, said: "Sepsis

and ne-

crosis are the great hopes of every patient with complete
granulopenia".

This was bases on the theory that these

conditions stimulated the·myeloblastio·aotivity of the
marrow and thus caused leukocytosis.

They believed that

in cases without sepsis and necrosis that one would not be
doing

to inject living staphylococci into the skin.

wr~ng

They have shown that turpentine intramuscularly in a rabb1 t causes necrosis and leukocytosis and have used this
treatment on one hWllan case with good results.

Jackson (54)

condemned sepsis as a therapeutic agent as there is •no.
evidence that it.can stimulate a paralyzed bone marrow•.
Strumia, (119), in 1934, pointed out that the

reaaon~for

the good results reported in some oases in which X-ray
therapy was used, was the destruction of a number of cells
and the liberation of disentegrating products.

It occured

to him that injections of leukocytes intramuscularly in
oases of agranulooytosis might furnish such

prod~eta

of dis-

integration, •containing large amounts of nucleic acid salts
in a form probably well tolerated and active•.
prepared a
said:

1

1

He therefore

leukocytic cream• from human whole blood.

He

011nioal response and the hematologic improvement

follo-wing the injections of leukocytio cream have been, on
the whole, strikingly parallel, and have progressed con-
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tinuously after they have begun.•

Blanton (6) reported

a case with recovery in which be gave 50 cc. of leukocytic
extract daily.

Sturgis and bis associates (111) stated

that there was no evidence that leukocytio cream was of
therapeutic value.
Splenectomy was perform.ed in one case reported by
Baldridge and Needles (a), in 1931.
thirty-five days after the operation.

The patient died
There was not the

usual rise leukocytes after the operation seen in other
cases, but there was the usual platelet response.

At ne-

cropsy the bone marrow showed an overgrowth of myelocytes
and myeloblasts almost as marked as in myelogenous leukemia.
Karberg and Wiles, (79) in 1938, reported seven oases
of agranulocytosis which were treated with yellow bone
marrow concentrate per os.

All Gf the patients recovered.

Whether used alone or jointly with other medication

1

it

usually causes a response in forty to forty-eight hours.•
From their-clinical tests

t~ese

authors have concluded that

the yellow bone marrow concentrate contains a substance or
substances which act to stimulate the maturation or liberation of leukocytes of the granulooyte series.

They stated

that their results bad confirmed the fundamental clinical
observations

c.

H. Watkins, of the Kayo Clinic, made on

patients treated with whole yellow bone marrow.

They added

75

that the concentrate they developed contained the active
principles without the bulky .inert neutral fa.ts

which made

the whole bone marrow unpleasant for clinical use.
Blood Transfusions.-- Transfusions have been used in
many of the reported oases, some of the patients recovering
and others dying.

There can be no definite conclusions

drawn as to its efficacy because in practically all oases
other measures were used along with the transfusions.

There

can be no great argument made in defense of transfusions as
there is no convincing evidence that they will actually
stimulate granulopoiesis.

Certainly the number of cells

would be small as compared to the amount

n~eded.

Doan (26)

supplied a possible defense for the advoeates of blood transfusions when he pointed out that it had been shown that he
normal blood contains nucleotides and the neutrophils on
diatntegration yield nucleic acid.
11

Thus in transfusion

an addition is made of the active principle".

He hastened

to add, however, that the concentration is very small and
would probably be insufficient in severe cases of myeloid
hypoplasia.

Jackson (54) is 11 deoidedly against transfusion"

stating that in some instances the white blood cell count
may fall following them.

In spite of these facts, many

men have used this form of therapy and are stilil. using it.
Such a use would seem to be essentially empirical.

How-

ever, such writers as Ordway and Gorham (86), in 1937,
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advised frequent small transfusions as a supportive
measure, and Sturgis and his co-workers (121) stated
that "multiple small transfusions of blood may be beneficial".

Meyer and Rosenberg, (80) after reviewing the

literature concluded that transfusicns seem to give
favorable results.
Irradiation of Bones.--Friedmann, in 1927 first
reported the results of irradiation.
of his cases showed improvement.
ported two more.

At that time four

A year later he re-

Kore recently Friedmann has reported

a series of 43 cases treated exclusively by X-ray.
these 13 were reported as cured.

Of

He selected one-twen-

tieth of an erytherma dose as the proper dosage based
on the Arndt-Schultz law that "small doses stimulate,
large doses destroy.•
ture it is

appa~ent

versally accepted·.

(127) From the cases in the litera-

that this dosage has been quite uniWaters and Firor ( 127), stated that

a variety of voltage factors have been used, from 130,000
to 200,000 volts.

In 1931, these authors reported the

cases of five patients treated with roentgen rays; four
were still living and the other was moribund when first
seen.

Their technic was as follows:

The lower extremi-

ties, the pelvis, the upper part of the humeri, and the
shoulder girdles were irradiated in the course of three
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or four treatments.

Voltage values of 200,000 with al-

uminum and copper filtration, both separately and combined, with effective wave lengths ranging from 0.197
to 0.161 angstrom units, were used.

The measurement of

dosage was effected by a dosimeter reading in roentgens,
600 units being adopted as the erythema dose, which was
agreed on at the Internation Conference of Radiologists
at Stockholm in 1928.

These writers explained the r.ationa.le

of X-ray treatment by pointing out that the marrow in the
shafts of the long bones in the adult consists mostly
of adipose tissue with little or no blood forming function.
Also that when excessive or pathological demand exists,
there is a formation of new centers of differentiation
of the myeloblasts into granular myelocytes, the adipose
tissue of the bone marrow being replaced by this newly
formed tissue.

They believe that it is possible that

irradiation might aid in the formation of this new tissue.
They concluded:

•The results of irradiation of the bone

marrow in angina agranulocytica, though not definitely
acertainable as yet, justify, in our opinion, a trial of
such therapy whenever possible for the unfortunate patients. 0
Doan (26), in 1932, believed that X-ray was theoretically
correct on the basis that if maturation arrest is present,
irradiation might work by "first destroying some of the
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myeloid foci and thus release some of the autogenousnucleotides which then supply the necessary stimulus
for maturation.•

He stated, however, that because of

the potentially destructive affinity of irradiation for
hematopoietic tissue, this form of therapy must be used
with great caution when stimulation is desired.

Taussig

and Sehnoebelen (123) reviewed the literature as to the
results of the various treatment, and, in 1931, reported
that the lowest mortality rate was found in those patients
who had been treated by irradiation.

They said:

1

0f the

methods of treatment at present in use, the most promising
appears to be the irradiation of the long bones by means
of minimal doses of X-rays.
Roentgen therapy was useless.

Jackson (54) stated that
Witte (131), in 1936, stated

that in his opinion Roentgen, and other forms of treatment, were not specific therapeutic agents.
Gorham (86), stated:

1

Tbe stimulating action of X-ray

bas been suggested but has proved of
may even be harmful."

Ordway and

li~tle

value, and

At the present time there seems

to be few advocates of Roentgen therapy for agranulocytosi s.
Liver Extract.--In 1931, Harkins (43) reported two
cases of agranulocytosis that recovered following the
use of liver ext.r-1\0_t as the chief therapeutic agent.
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Foran and hie associates (37) reported remissi6ns in
all five of their cases followin liver extract therapy.
One died later in a recurrence during an attack of
lobar pneumonia; the other four have
said:

1

~emained

well. They

The resemblance of the leukocytic increase to

the retioulocyte rise in pernicious anemia was very
ing in four cases.•.

stt1k~

They used the equivalent of 100

grams of liver every eight to twelve hours intramuscularly
or intravenously.

Jackson (54), in 1931, said:

•At

present the ultimate value of liver therapy in agranulooytosis cannot be estimated.

It can only be said that

a few patients have been successfully treated.

•Ordway

and Gorham (86), in 1937, stated that liver extract may
be effective.

They advocate that it be given intramus-

cularly in large doses,

300.

of concentrated liver extract

every three hours, amounting to 10 or 12 cc. daily.

They

suggested that frequent white blood counts be made during
the day

1

to guage the effect•.

They observed that results

apparently vary widely according to different writers;

1

in

some instances brilliant success has been reported, in other
cases, disappointing failure.•

Parker and Kr,cke (87)

made determinations on various preparations of liver extract and found the presence of a large amo'1nt of reduced
glutathione.

They suggested that this substance may_ be

partially responsible for the therapeutic effect of liver
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extract in some of the leukopenic diseases, based on
their experiments which showed a depletion of glutathione in the bone marrow and blood of animals with a
depressed bone marrow.

Murphy (84), in 1936, reported

that he had treated six typical cases of agranulocytosis with daily, or more frequent injections of liver
extract, with recovery in each instance.

He believes

that usually liver therapy has not been adequate where
recovery has not followed.

However, he considered that

sufficient evidence had not been furnished to establish
such therapy as the treatment of choice, but suggested
that further experience may demonstrate that this preparation is •as valuable in the control of this disease
as it is in pernicious anemia.•
Nucleotide Therapy.--The nucleic acids are present
in the nuclei of cells of the animal body.

According to

the prevailing view, the nucleic acids are combined
with protein, thus constituting the so-called nuoleoproteins.

On partial hydrolysis,

n~cleoproteins

yield

a protein residue and a protein-nucleic acid complex
which has been called nuclein.

If the cleavage is carried

somewhat further, the nuclein yields protein and nucleic
acid as cleavage products.

Of the foodstuffs, glandulaz

tissues, such a thymus, pancreas, liver, and kidney, are
especially rich in nucleic acid.

On hydrolysis nucleic
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acid yields purine and pyrimidine nucleosides and phosphoric acid.

The purine nucleotides on further hydrol-

ysis finally yield the purine bases, adenine and guanine.
(Bodansky ( 9).
Doan (26), in 1932, stated that nuclein therapy was
suggested, on purely empiric groilnds, as early as 1893,
to •increase the germicidal power of the blood in diseases
of m1crobiD origin!•

He stated that it is now known that

the increase in leucocytes reported and attributed to
nucleic acid in the earlier investigations was well within
the normal range of physiologic fluctuation and not of
sufficient magnitude to influence any pathologic process.
Doan and his associates (28), in 1928, obtained a definite
and usually considerable leukocytusis following intravenous injections of one gram of sodium nucleinate into
normal rabbits.

They found that a preliminary leukopenia

occurred, sometimes lasting for a number of hours, which
they attributed to a temporary storage of the granulocytes in the spleen.

In 1924, Jackson (52) demonstrated

the existence of pentose nucleotides in normal human blood.
Doan and his co-workers (28) secured adenine and guanine
nucleotides from Jackson's laboratory, and chemically
pure crystalline adenylic and guanylic acids from P. A.
Levene of the Rockefeller Institute.

All of these pro-

ducts gave an immediate neutrophilicresponse without pre-

-------~----------------------------

aa

liminary leukopenia.

Reznikof:f' (96), in 1930, reported

the first clinical application of nucleic acid derivatives.

He stated that, since the other blood elements

are usually not affected, this disease should lend itself to treatment by

1

the stimulation of the polymor-

.

phonuolear elements by nucleotides such as adenine suflate and guanine hydrochloride.•

He reported three oases

with recovery by the administration of 0.5 gram of the
nucleotide twice 1n twenty-four hours.

He found that

within six hours there was some response and usually the
increase in·granulocytes was marked after the second dose.
In 1931, Jackson and bis associates (52) reported recovery in fourteen out of twenty oases of profound leukopenia following large doses of nucleotides.

The used

the unbroken pentose nucleotide, called K-96, which was
prepared by Smith, Kline and French Company.

In the

patients who recovered the first sign of improvement
occurred between the third and seventh day, usually on
the fifth day.

The total and differential counts were

invariably normal in ten days, S?metimes in eight.
writers commented:

1

These

Tbe consistency with which the re-

action ooctirred on or about the fifth day is of great
significance.

It is at this time that the reticulooyte

rise begins to take place following liver therapy in per-
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nicioue anemia.

"This reaction would tend to show that

the time for the maturation of the granulocytes is abcnt
the same as that of the erythrocytes.

Howe~r,

Beck (3),

in 1933, stated that there was no definite experimental
proof, that nucleotide K-96 supplied a maturation factor
for granulocytes.

Doan (25), experimenting on normal

rabbits with pentose nucleotide, in 1932, produced not
only an extensive degree of myeloid hyperplasia, but also
an extramedullary myelopoiesis in the kidneys and spleen.
He (25), later, stated that the average effective dosage
of Nucleotide K-96 in human cases of agranulooytosis had
been four to six grams in his experience at that time.
He stated that the experimental studies he had made on
normal rabbits justified three conclusions:

(1) Nucleic

acid and its degradation products exert a chemotactic
effect on normal myeloid foci with a prompt effective
increase in the delivery of granular leukocytes to the
peripheral circulation under a controlled physiologic or
rhythmic mechanism; (2) Repeated large intravenous inj ecticn s do not tend to exhaust nor cause a malignant

hyperplasia of the myeloid elements in normal animals.
(3) A short course of injections stimulates a myeloid hyperplasia of normal marrow without otherwise injurious
consequences.

Attenticn should be called to the fact that
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Doan admitted that hie experiments were done upon normal
animals.

To draw conclusions as to the possible effect

of such therapy in the case of human agranulocytosis
hardly seems logical.

Doan (26) based his work on the

hypothesis that the degradation products of senile and
disintegrating cells are an integral part of the normal
mechanism for maintaining cellular equilibrium in the
Marrow and the blood stream.

He, therefore concluded

that in those oases "presenting an etiology essentially
intrinsic and related to an insufficiency of the myelop- .
oietic function of bone marrow, the more rational treatment should be the supoly to the body of a concentrated
preparation of the active principle affecting directly
the myeloid centers•.

Doan included the following table

to show the efficacy of nucleotide therapy.
are based on the literature to 1931:
Oases.
Therapy
Deaths
Many
Untreated
l.
179
133
2. Miscellaneous
Arshpenamine
·
24
33
3.
53.
34
Blood
Transfusion
4.
64
34
Irradiation
5.
44
ll
6. Nucleotide

These figures

Mortalitl

96

%

7, ~
72 ~
64 ~
53 ~
25 ~

In 1933, Jackson (55), reported that he began treating systematically oases of agranulocytosis and "malignant neutopenia secondary to sepsis• with pentoae nucleotides (PentnucltWtide, N.N.R., formerly Nucleotide K-96).
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He stated that he had treated, or had reported to him,
91 cases treated with pentnucleotide with a mortality
of but ~.

However, he emphasized the tendency to re-

lapse and the possible. occurrence of d!ath in the second
or third attacks.

In the usual case of agranulocytosis,

Jackson uses 10 cc. of pentnucleotide intramuscularly
two or three times daily until the white count has definitely risen.

Thereafter 10 co. are given once a day

until the white count has been normal for three successive days.

He recommends l'arger doses in the most severe

oases up to as much as 40 cc. per day.

Given intramus-

cul a:rly this preparaticm usually produces no marked untoward reactions although there may be some local pain and
not rarely there is nausea or vomiting shortly after administration. Jackson pointed out that no definite beneficial results are to be expected before the fourth or
fifth day.
!n 1933, Reznikoff (97), reported fifteen oases of
agranulocytosis in which he used adenine sulphate.

There

was total recovery in eleven patients and almost all of
them showed response in twenty-four hours.

He used, for

an adult, one grain of adenine sulphate boiled in 35 to
40 cc. of physiologic saline, administered by vein three
times per day for a least three days.
sized the faot

~hat

This writer empha-

in a disease such as agranulocytosis,
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spontaneous recovery is so common that any evidence such
as he has reported may be only circumstantial.
Jackson, Parker, and Taylor (59) made an analysis,
in 193.2, of 69 oases of malignant neutropenia treated with
pentose Nucleotide. (K-96) and found that 74 per cent of
the patients had

recovere~.

· They stated,

1

The favorable

clinical and hematologic response took place rather
.

'!

sharply about the fifth day of treatment, irrespective
of how long the patients had been ill.

Sturgis and his

'

associates (121) concluded, in 1935, that there was more
data in support of the effectiveness of pentnuoleotide
therapy than of any other form of treatment.

The report

of Jackson and Parker (58), in 1935, offers more confirmatory data.

These authors reported a series of 103

patients treated with Pentnuolebtide (N.N.R.) in which
the mortality rate was but 33 per cent.

Jackson (54),

in a later paper, written in the same year, suggested
that one reason that some unfavorable results with pentnucleotide had been reported was because less than 40 cc.
daily, his reeommended dose, had been given.

He

admitted

that, unfortunately, this dose may cause such severe reactions in some patients that it cannot be tolerated.

Be

'.-'

added also that a complete absence of granulocytes in the
peripheral blood is probably incompatible with life and
therefore despite an adequate dosage, the patient may die
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before the beneficial result occurs.

Of all forms of

treatment discussed thus far, the reports of cases and
series of cases treated with nucleic acid derivatives
· would certainly indicate that that form of therapy comes
the nearest to being of value in agranulocytosis.

There

are on the other hand, several observors who have failed
to note

~Y

benefit .from such treatment.

In 1937, litz-

Hugh (34) reported ·that the treat1nent in his hands had
been of no apparent value.

Howev.er, he stated that a

possible explanation for.his failure lay in the fact that
he did not stop the use of such drugs as aminopyrine in
his oases until after the report of Madison and Squier
in 1934.

In Witts' (131) opinion neither pentnucleotide,

transfusions, liver extract nor Roentgen treatment are
specific therapeutic agents.
Preventive Treatment.-~There was little definite information in the literature concerning the prevention of
agranulocytosis or the prevention of re·currence of acute
attacks until after 1931 when R. R. Xracks first drew
attention to the possible etiologic importance of certain
benzene ring drugs.

Roberts and Kracke (lOQ, who found

an incidence of a mild granulopenia in one out of four of

a,ooo

private ambulatory patients, stated that the com-

plaints of weakness, exhaustion or fatigue were twice as
frequent in such patients as in those with normal white
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cell counts.

From this finding it would seem that rest,

and freedom from mental and emotional strain, would be
advisable in patients showing a low granulocyte count as
a possible preventative measure against the development
of agranulocytosis.

With the great accumulation of data

.
supporting the etiologic relationship between certain
'

drugs (related to aminopyrine or the benzene ring), and
the disease under discussion has lead the majority

o~

authors to the opinion that all such drugs
should be with.
'

drawn in the event of beginning development of
penia.

granulo~

Jla.ny authors go further and say that such drugs

should not be used or should be used only rarely and
sparingly.

Kracke and Parker (69) expressed the belief,

in 1935, that the most valuable therapeutic measure for
agranulocytosis is to refrain carefully from the use of
drugs containing aminopyrine.

Fitz-Hugh (34), in 19a7,

reported that in his series of such patients the 'best results, as far as therapy was concerned, were in the group
of patients who stopped ingesting aminopyrine.

He said:

•It would seem reasonable that the earlier the diagnosis
is established, and the earlier the offending drug is
stopped, the better the outlook.•
Kracke, iS7) in 1938, expressed the views of the
majority of writers when he wrote that in an effort to
to control the incidence of agranulocytosis, the physician

should refrain from the use of aminopyrine or analgesic
agents that contain it;

second, he should warn his pa-

tients against the dangers of self medication, particularly the purchase and use of pain-relieving remedies
for which the formula is not available;

third, the phy-

sician who is using agents such as sulfanilamide in the
treatment of severe infectious states, or is using
arsphenamine and other organic arsenicals, should watch
the patient carefully for signs of .possible hematologic
depression by frequent studies of the blood;

fourth,

the physician should take an active part in the program
of public instruction relative to the dangers of these
preparations, for only if he does so can the public become informed as to these dangers.

Certainly it will not

get this information from drug stores and pharmaceutical
manufacturers.
SUYM.ARY

1.

The term agranulocytosis, although criticized by

numerous writers because of its intrinsic ambiguity, has
become so firmly imbedded in the medical literature ·and
the vocabularies of the clinicians that it is believed
that it should be retained.

The various other names sug-

gested are, admittedly, more descriptive and perhaps more
accurate, but a common brief term, universally accepted,
will always be more desirable.
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2.

Although there was no great interest in the dis-

ease until after the appearance of the original article
by Schultz, (lOS) in 1922, data has been offered to show
that there is no reason to believe that the disease did
not exist prior to that time.

3. The report of Lovett, (76) in 1924, of the first
case in this country, Kracke's report of a case, (49) in

1931, in which the relationship of coal tar drugs was first
stressed, Fitz-Hugh and Krumbhaar•s suggestion, (36) in

1932, that a maturation arrest was the principal pathology,
and Plumer's (93) report of the first case due to sulfanilamide, in 1937, are other high points in the history of
agranulocytosis.

4. The numerous theories of the etiology and pathogenesis have been discussed at some length.

One definite

conclusion can be drawn from the voluminous literature on
this subject:

There is, although gradually being reduced,

a certain number of cases of agranulocytosis in which the
cause cannot be determined at the present time.

5. Biopsy and autopsy studies have confirmed, in
the minds of most authorities, that there is present in
the bone marrow an arrest of the maturation of the granulooyte development not unlike the arrested maturation of
erythrocytes in pernicious anemia.

The cause of the ma-

turation arrest, however, remains obscure.
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6. Sufficient evidence has been presented, I believe, to incriminate certain drugs, notably aminopyrine
and its derivatives, dinitrophenol, arsphenamine, and
sulfanilamide, in a large number of oases.

The mechanism

by which such drugs produce the disease is not understood.
The evidence does not show, however, that the drugs, per
se, are toxic to all individuals.

An allergic or idio-

syncratic phenomenon must be assumed on the basis of the
available data.

7. For the sake of completeness, a brief discussion
of the pathology, symptoms, signs, blood picture, and
prognosis of the disease has been included.

s.

A review of the treatment employed for agranulo-

oytosis reveals that almost innumerable agents have been
prescribed.

The fact that spontaneous recoveries are known

to occur make it difficult to draw defini-te conclusions as
to the efficacy of the various forms of treatment.

9.

lucleotide therapy in adequate dosage, according

to statistics, offers the best hope for the patient as far
as active treatment is concerned.

Recent good results

with liver extract and yellow bone marrow concentrate are
encouraging but not conclusive.
10.

The withdrawal of any drugs, eapecially those

containing a benzene ring, which might possibly have an
etiologic bearing on the disease is to be definitely
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recommended.

Such passive treatment in many cases has

resulted in the patient's recovery.
11.

Physicians should refrain from the use of amino-

pyrine drugs or analgesics containing it as much as possible.

Close observation of the patient's blood picture

during the administration of drugs containing the benzene
ring is essential as a prophylactic measure.

P~tients

should be warned of the aanger of the indiscriminate use
of pain-relieving drugs for which the formula is not
available.
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